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EVOLUTION AND DIVERGENCE OF THE STRUCTURAL AND PHYSICAL 
PROPERTIES OF DNA BINDING BY METHYL-CYTOSINE BINDING 
DOMAIN FAMILY MEMBERS 2 AND 3 
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Doctor of Philosophy at Virginia Commonwealth University. 
   Virginia Commonwealth University, 2014 
Major Director: David C. Williams, Jr., M.D., Ph.D., Associate Professor, 
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The studies presented in this dissertation, Evolution And Divergence Of The Structural 
And Physical Properties Of DNA Binding By Methyl-Cytosine Binding Domain Family 
Members 2 And 3, pertain primarily to two key epigenetic regulators involved with the 
biological interpretation of methylated DNA marks. We provide insights into the 
emergence and evolution of the MBD2 and MBD3 and how those molecular entities 
influence heritable changes in gene activity. We further provide details regarding the 
mystery surrounding MBD3 function and the MBD2-mediated capacity of primitive 
animals to carry out methylation-specific epigenetic mechanisms. In chapter two, we 
describe the DNA binding properties of MBD2 and MBD3. This study provides 
information regarding previously unidentified MBD3 binding properties and potential 
biological function. In chapter three, we show that sponges demonstrate a MBD2-
mediated capacity for binding methylated DNA sites, recruit NuRD components in vitro, 
and knockdown of MBD2 in the freshwater desmosponge, Ephydatia muelleri, promotes 
an abnormal growth phenotype.  
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Chapter 1- Introduction 
 
 
When we refer to DNA, we often speak of the molecule as a “template” used in the 
production of proteins. While one may picture a machine assembly line wherein pieces 
are assembled to construct a whole, operational structure, DNA functionality often does 
not result in the production of identical parts. DNA serves as a manuscript that may be 
interpreted in a number of different ways with many different outcomes. This script may 
be altered, thereby changing meaning, and thus interpretation. Alteration may occur in 
the form of changes to letters and words or even sentence structure. But, modification 
may also involve no apparent change to the words, or their meaning. Subtle emphasis or 
de-emphasis of words, sentences, or whole sections of the script may occur leading to the 
disuse of those portions of script. When speaking of DNA, these subtle changes in 
emphasis often result in alteration of gene function.  
Epigenetic phenomena are processes that cause heritable changes to gene 
expression without altering genetic sequences. The coding of these occurrences can 
reside in modifications to histones and DNA. Scientists study these events through a 
variety of biochemical, bioinformatics, and molecular biology approaches. Study of 
epigenetic phenomena along with the functional and mechanistic changes they cause has 
expanded not only our understanding of human health and disease, but also of the 
evolutionary processes driving vertebrate evolution.  
Collected epigenetic information is translated into an understanding of the 
“epigenome”. To better understand the biological significance of these phenomena, the 
epigenome must be mapped. Unfortunately, epigenetic programming is highly variable 
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and tends to be subject to the internal conditions of individual cells. Nevertheless, 
numerous research projects are underway with the aim of elucidating epigenetic signaling 
events on several levels.  
This thesis represents one of those projects. Specifically, the information presented 
herein sheds further light on the physical mechanisms and dynamics of epigenetic 
machinery at both ends of the metazoan spectrum. By describing current protein-protein 
and protein DNA interactions in their evolutionary context we can better elucidate the 
processes by which new protein properties emerge, the underlying mechanisms by which 
biological systems function, and how the diversity of living forms in nature came to be. 
 
1.1 DNA Methylation 
 
DNA methylation is the most abundant and extensively characterized of the 
identified eukaryotic epigenetic modifications (1). From plants to mammals, DNA 
methyltransferases (DNMTs) carry out DNA methylation through the transfer of a methyl 
group from the methyl donor S-adenosyl methionine (SAM) to a cytosine (figure 1.1); the 
addition of a methyl group to the 5-position of the cytosine ring in a cytosine-guanine 
dinucleotide (CpG) forms 5-methylcytosine (5mC). In humans, this phenomenon is 
important for numerous processes including embryogenesis, stem cell differentiation, 
genomic imprinting, X chromosome inactivation, and has been associated with 
transcriptional silencing and tumorigenesis (1-4). 
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1.1.1 DNA methylation is evolutionarily ancient 
 
 DNA methylation represents an important epigenetic signal found throughout the 
three domains of life, though the roles and targets of DNA methylation vary among the 
kingdoms of organisms. The process may have evolved in bacteria as a barrier against 
genome invasion by viral or other foreign DNA (3). The high degree of conservation in 
the catalytic motifs of DNMTs across prokaryotic and eukaryotic species also suggests 
that cytosine methylation is an ancestral mechanism.  
 In kingdom Eukaryota, 5mC and DNMTs are found in animal, plant, fungal, and 
protozoan lineages (5-7). Methylation patterns are also observed at the very base of the 
animal kingdom in sponges (8) presupposing the omnipresence of methylation and 
methylation machinery throughout higher levels of Eukaryota. Interestingly, this is not 
the case. 
 Patterns of DNA methylation changed during the transition from invertebrate to 
vertebrate life. Vertebrates tend to show global methylation often in promoter regions 
while invertebrates harbor “mosaic” methylation patterns in gene bodies (9). The global 
Figure 1.1: Image showing the process of DNA methylation.   
!
CH3 
DNMT 
SAM CH3 SAH 
Cytosine 5’ Methyl-cytosine 
	   4	  
methylation observed in vertebrates appears to correlate with an expansion of the DNMT 
and MBD families (10).  
 While 5mC and DNA methylation are abundant in vertebrates, these marks are not 
ubiquitous, and further, many invertebrates lack methylation altogether (9). Though 
several invertebrate organisms do not experience detectable methylation, including 
several commonly used invertebrate model organisms (e.g., yeast, fruit fly, and worm) 
(11), research continues to demonstrate the pervasiveness of cytosine methylation as an 
evolutionarily ancient genomic regulatory mechanism. Given that DNA methylation is a 
mechanism for regulating endogenous gene expression and reducing transcriptional 
noise, a reduction in unnecessary gene expression may have permitted the increase in 
gene number and in complexity that characterizes metazoans, i.e., animals (12). 
 
1.1.2 DNA methylation in sponges 
Sponges represent the most ancient and primitive metazoan lineage (13) and, 
despite their distinct morphological separation from other animals, studies of sponges 
have shed light on the molecular evolution of animals. Like higher animals, the sponge 
genome harbors genes crucial for growth, differentiation, cell-cycle control, cell 
adhesion, innate immunity, and allorecognition (14).  Sponges also share in common with 
animals numerous transcription factor, sensory transduction, and cell adhesion genes 
(15). Sponges, however, have nearly two times more genes than eumetazoans (i.e., “true” 
animals) (16), discrediting the idea that animal evolution resulted from an increase in the 
number of genes. 
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Though the recently sequenced Amphimedon queenslandica genome indicates the 
numerous similarities in the molecular framework between sponges and other animals, 
much is still unknown regarding the epigenetic machinery in place at the dawn of 
metazoans. Thus, analysis of sponge epigenetic mechanisms and structures can 
potentially uncover the genomic innovations allowing for the multicellular life and shed 
light on the evolutionary underpinnings of cancer. Indeed, numerous “founder” genes 
associated with the appearance of metazoan multicellularity connect with cancer onset 
and progression (15).  
Earlier analysis of sponge methylation levels detected up to 9.4% 5mC in a sample 
of 15 sponge species (8). The A. queenslandica genome exhibits germline cytosine 
methylation indicated by a depletion of CpGs with corresponding TpG and CpA 
dinucleotide excess relative to overall GC content. Four putative orthologs of DNMT1 
were identified in A. queenslandica along with one copy of a DNMT-like gene (Pohlman 
D, unpublished data). Swiss-Prot analysis of A.q. revealed presence of partial sequences 
similar to the glycosylase domain of MBD4 along with other predicted MBD proteins, 
including a MBD2-like protein (8, 17). 
Another sponge, Ephydatia muelleri, is an emerging model system to study aspects 
of animal development (14). E. muelleri harbors epigenetic machinery, discussed in detail 
later, that presumptively allows for the same epigenetic signaling as observed in higher 
animals. Two supposed orthologs of DNMT1 were discovered in the E. muelleri genome 
along with one copy of a DNMT3-like gene. An ortholog of MBD2 (i.e., Mbd2/3) was 
also detected (Pohlman D, unpublished data). Despite the presence of DNMTs and MBDs 
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in these two sponges, the methylation pattern (i.e., global or mosaic) has not yet been 
determined.  
 
1.1.3 DNA methylation in mammals 
 
DNA methylation occurs at 70-80% of CpGs in vertebrates although this 
dinucleotide represents a very small percentage of the base composition of DNA (18). 
The CpGs comprising the genome are primarily found concentrated into regions known 
as “CpG-islands” (CGIs) and represent a very small percentage (1-2%) of the genome in 
its entirety (19, 20). Approximately 60% of active genes contain CGIs in their promoter 
regions. These regions are largely unmethylated and less subject to CpG loss experienced 
by the rest of the genome whereas CpGs outside of CGIs tend to be very highly subject to 
methylation (19). Different cell types show different gene expression patterns, an 
observation that suggests that CpG methylation differs across different cell types. 
DNA methylation patterns become distinctly altered early in mammalian embryonic 
development (21, 22). Fertilization initiates a period of genome-wide DNA 
demethylation and subsequent de novo methylation necessary for methylation 
reprogramming in somatic cells after implantation and resetting gamete-specific patterns 
in germ cells. Beyond these genome-wide changes, de novo methylation and 
demethylation occur during tissue-specific differentiation (23-25). 
DNMT family members DNMT1, DNMT3A, and DNMT3B maintain mammalian 
DNA methylation patterns through the activity of a conserved C-terminal 
methyltransferase domain (5). DNMT1 preserves DNA methylation patterns during 
replication by adding methyl groups symmetrically opposed to methyl groups of hemi-
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methylated CpG sites found on newly replicated DNA. DNMT1 localizes to these sites 
likely assisted by two proteins that bind hemi-methylated DNA: the cofactor ubiquitin-
like, containing PHD and RING finger domains 1 (UHRF1) and proliferating cell nuclear 
antigen (PCNA) (21, 26). DNMT3A and DNMT3B have no preference for 
hemimethylated CpGs. Both establish methylation patterns during early stages of 
embryonic mammalian development through de novo DNA methylation activity (27).  
Though cytosine methylation is considered to be a stable modification, a variety of 
mechanisms have been proposed for demethylation. During one such mechanism, 5mC is 
oxidized to form 5-hydroxymethylcytosine (5hmC) in mammals by the ten eleven 
translocation (TET) family of enzymes. Several mechanisms (e.g., the DNA base 
excision repair, BER, pathway) are proposed to occur subsequent to the conversion of 
5mc to 5hmC and ultimately lead to a decrease of the methylation mark (28, 28, 29). 
These demethylation pathways may be important for normal developmental processes, as 
well as the global hypomethylation observed during cancer progression; downstream 
removal of 5hmC may be a critical event epigenetic gene regulation (28, 30, 31). 
 
1.1.4 Aberrant DNA methylation and cancer 
In normal cells, DNA methylation occurs primarily in repetitive genomic regions, 
including satellite DNA and parasitic elements (e.g., long and short interspersed 
transposable elements) (32). DNA methylation has been linked to regulation of gene 
expression and genome stability. CGIs around promoters are commonly unmethylated 
(33) with few exceptions (e.g., differentially methylated regions associated with gene 
imprinting). Despite early predictions gene body methylation has been associated with 
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transcription (34, 35). Methylation of gene promoter and enhancer regions, however, 
correlates with transcriptional silencing through interference of transcription factor 
binding and formation of heterochromatin by methyl DNA-binding proteins (MBDs) 
(36).  
The relationship between disrupted DNA methylation patterns and cancer was first 
observed when hypomethylated cancer cells were identified and has since been 
extensively studied and argued (37, 37-39). Recent advances in our understanding of 
epigenetic modification has shown that human cancer cells undergo global changes in the 
epigenetic landscape including genome-wide hypomethylation concurrent with promoter 
CGI hypermethylation of tumor suppressor genes including BRCA1, VHL, and 
p16/INK4a (40); these alterations are now considered hallmarks of cancer. Further, these 
cells harbor numerous genetic alterations that, along with aberrant changes to the 
methylome, promote cancer progression. 
The mechanism of gene silencing by promoter hypermethylation can occur by 
several modes including direct obstruction of transcriptional machinery and nucleosome 
remodeling activities that make transcriptional start sites inaccessible. DNA 
hypomethylation is often an early tumorigenic event that occurs in cancer cells primarily 
through demethylation in genomic repetitive regions (32, 40, 41). DNA demethylation 
can have mechanistic implications: removing methyl groups relaxes chromatin structure 
allowing histone acetylation and the binding of transcriptional complexes. Thus, loss of 
methylation can lead to activation of normally silent genes, including oncogenes such as 
those in the ras family (42). Relaxed chromatin also may be more prone to genetic 
mutation and chromosomal rearrangements (43). 
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1.2 Methyl-cytosine binding proteins 2 and 3, NuRD, and vertebrate evolution 
 
 
The canonical MBD binds symmetrically related methyl-CpG dinucleotides. 
Though several MBD proteins have been identified, only MBD2 and MBD3 homologs 
have been identified in invertebrate genomes. MBD2/3 is the presumed invertebrate 
ancestor to the vertebrate MBD2 and MBD3 proteins; a single gene encodes MBD2/3, 
whereas two separate genes produce MBD2 and MBD3 (44). Vertebrate Mbd2 and Mbd3 
possess nearly identical intron-exon structure and MBD2 and MBD3 exhibit 71% 
sequence homology. These and other observations have led to the supposition that a gene 
duplication event resulted in two genes distinct from Mbd2/3 at a time concurrent with 
the emergence of vertebrates (3). 
Mammalian MBD2 selectively binds methylated DNA whereas MBD3 does not, 
although it does preferentially localize to methylated CpG dinucleotides (45). MBD3 
differs from MBD2 at two amino acid residues critical for mCpG binding. In mammalian 
MBD3, a histidine residue (amino acid position 30) and a phenylalanine (position 34) 
replace lysine and tyrosine residues in MBD2, respectively. The latter substitution 
disrupts the interaction between the methyl group of methylcytosine and the MBD3 
MBD; selectivity for methylated DNA is greatly reduced. Although these substitutions 
clearly abolish methyl-CpG selectivity, the biological purpose of MBD3 and much of its 
structure remain unclear. 
MBD2 and MBD3 structural components primarily consist of a methyl-cytosine 
binding domain followed by a region implicated in binding the RbAp46/48 homolog p55 
(46) and a C-terminal coiled-coil region. Human MBD2b shares 70% sequence homology 
with human MBD3 prompting in vitro comparisons between the two proteins. The human 
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MBD2a isoform possesses an N-terminal GR-rich region that likely serves as a DNA 
tether yet operates with lower affinity for methylated DNA in vitro than MBD2b (47). 
 
 
Structural analysis of other MBD family members (i.e., MeCP2 and MBD1) 
elucidated the methyl-cytosine binding domain selectivity for mCpG dinucleotides: base-
specific interactions between conserved arginine and tyrosine residues and the mCpG 
dinucleotide. A hydrogen bond network forms between arginine residues 22 and 44 and 
the symmetrically related guanine bases of the mCpG dinucleotide. The aliphatic portions 
of the arginine residues further pack against the methyl groups of the symmetric methyl-
!!!!!!! ! !!!!!!!!! !!!!!!!!!! !!!
GR-rich 
region 
MBD2a 
MBD p55 binding region 
(p55BR)  
Coiled-coil 
region 
MBD2b 
MBD p55 binding region 
(p55BR)  
Coiled-coil 
region 
MBD3 
MBD p55 binding region 
(p55BR)  
Coiled-coil 
region 
Figure 1.2: MBD2 and MBD3 domain organization. GR, glycine-arginine repeat region; 
MBD, methyl-binding domain. 
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cytosine bases. The critical tyrosine residue forms a hydrogen bond with the methyl 
group of a methyl-cytosine through water-mediated interaction (48, 49). Analysis of the 
MBD2 MBD solution structure elucidated a similar binding event, but further revealed a 
specificity for CGG sequences that enhances the selectivity of chicken MBD2 (cMBD2) 
for mCpGs driven in part by additional hydrogen bonding formed between lysine 30 and 
the second guanine of the mCGG sequence (50). 
Comparison of cMBD2 and MBD3 MBD solution structures reveals high similarity 
between the two proteins and both complement the global fold of other methyl-cytosine 
binding domain proteins: the topology consists of a four-stranded β-sheet, a flanking α-
helix, and a C-terminal loop (45, 50). The second and third beta sheets form a long, 
finger-like projection that extends into the major groove to form critical DNA-specific 
contacts. A long loop connects the strands forming this projection, and for cMBD2, 
residues found in this loop form contacts with DNA that further stabilize the interaction 
with methylated DNA (50). Notably, this loop is less well ordered for MBD3 (45); the 
absence of the amino acids crucial for methylation selectivity at the base of the projection 
destabilizes its overall structure, thereby disrupting the hydrogen bond network necessary 
for methylation-specific binding. Again, such information brings into question the 
functional role of MBD3. 
Other observations further highlight the mystery surrounding mammalian MBD3 
function: (1) Non-mammalian vertebrates have been identified that share high amino acid 
sequence identity with mammalian MBD3 yet preferentially bind methylated DNA, e.g., 
amphibian MBD3 (3, 47); (2) while MBD2-null mice experience only subtle defects 
MBD3-null mice die early in embryonic development (51); (3) both proteins associate 
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with the Mi-2/nucleosome remodeling and deacetylation complex (i.e., NuRD complex) 
in a mutually exclusive manner (52); (4) MBD3/NuRD bars reversion of murine stem 
cells to ground-state pluripotency (66); (5) MBD3/NuRD localizes to promoters (53, 54), 
gene bodies, and enhancers of active genes (54). 
 The NuRD complex is an ATP-dependent chromatin remodeling complex that 
facilitates multifaceted chromatin remodeling activities and is implicated in 
transcriptional silencing. The complex tethers to DNA through its associated MBD 
protein, thus coupling reading methylation marks with histone modification.  As seen in 
figure 1.3, six core proteins comprise the complex and constitute its ability regulate gene 
expression at the chromatin level: MBD2 or MBD3; histone deactylase (HDAC) 1 or 
HDAC2; chromatin remodeling enzyme Mi-2α (CHD3) or Mi-2β (CHD4); p66α 
(GATA2A) or p66β (GATA2B); metastasis-associated (MTA) protein (i.e., MTA1, 
MTA2, or MTA3); retinoblastoma-binding protein (RBBP; also known as RbAp48) 4 or 
RBBP7 (RbAp46). The MBD protein targets the complex to DNA while HDAC1 or 
HDAC2 enzymatically removes acetyl groups from histone tails. The Mi-2 subunit 
carries out chromatin remodeling in part by repositioning nucleosomes. The p66α, p66β, 
RBBP4, and RBBP7 subunits are likely structural subunits of the complex that interact 
with histone tails. The p66α/β proteins contain two highly conserved regions: an N- 
terminal coiled-coil domain (CR1) and a C-terminal GATA-like zinc finger domain 
(CR2) (55, 56). The MTA protein is thought to localize the complex to different cell-
specific targets by associating with transcription factors (57). 
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The coiled-coil regions of MBD2 and MBD3 bind the p66α coiled coil domain 
(CR1) forming a high affinity heterodimeric complex that recruits Mi-2 and correlates 
with in vivo methylation dependent transcriptional repression (58). This interaction is 
unique amongst coiled coils in that the heterodimeric complex forms from anti-parallel 
association between two peptides that are largely monomeric in isolation. Helical content 
and specific electrostatic interactions between charged residues on the individual coiled 
coil domains drive the high affinity binding observed (59). This suggests that isoforms of 
MBD2, MBD3, and p66 exhibiting a reduction in helical content will bind with reduced 
affinity for p66. Indeed, this is the case for MBD3L1 and MBD3L2, homologues of 
MBD3 lacking a methyl-cytosine binding domain but containing a C-terminal coiled coil 
(59). 
MBD2 and MBD3 contain a region implicated in binding the RbAp46/48 homolog 
p55 in Drosophila (46). The p55-binding region (p55BR) is found between the methyl-
cytosine binding domain (MBD) and the coiled-coil domains of MBD2 and MBD3 and 
5 
 
 
 
 
Figure 1.1: Components of MBD2-NuRD. A) Schematic representation of the MBD2-
NuRD complex. B) Domain organization of MBD2b: MBD is methyl binding domain; 
CC is coiled-coil domain C) Domain organization   of   p66α:   two   conserved   regions   are  
seen. CR1 is a coiled coil domain; CR2 includes a GATA zinc finger domain. 
 
 
 
 
 
Figure 1.3: NuRD complex architecture. The human NuRD complex contains one homolog of six 
different core proteins: MBD2 or 3; HDAC 1 or 2; RbAp 46 or 48; p66α or β; Mi-2α or β. 
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recruit the NuRD core components RbAp48, HDAC2 and MTA2 (Desai, MA, 
unpublished data). This region has been determined to display a largely unstructured 
architecture in isolation and yet enhances the affinity of MBD2 to methylated DNA 
(Desai, MA, unpublished data). 
Genes for NuRD complex components have been identified in the earliest 
metazoans including Amphimedon queenslandica and Ephydatia muelleri (unpublished 
data, Pohlman D.) but it is unclear if their products form a functional complex. We 
recently found, discussed in detail later, the E. muelleri MBD2 coiled-coil region binds 
the E.m. p66α coiled-coiled domain with low affinity. Further, the human MBD2 coiled 
coil domain binds E.m. p66aCR1 and vice versa with higher affinity than the two E.m. 
components in complex together (unpublished data). Surface plasmon resonance shows 
that the Ephydatia MBD2/3 methyl-cytosine binding domain binds methylated DNA with 
approximately 200-fold higher affinity than unmethylated DNA, similar to that of the 
human MBD2 (unpublished data). Isothermal titration calorimetry indicates that the 
coiled-coil region from the E.m. MBD2/3 binds to the human p66αCR1 with higher 
affinity than the weakly binding Ephydatia p66αCR1 isoform; the human isoforms bind 
each other with an affinity approximately 1,000-fold higher. These findings suggest that 
as coiled coil domains evolved in vertebrates, high affinity binding between these NuRD 
components developed so as to decrease competition with other coiled-coil proteins. 
 
1.3 The coiled coil motif in evolution 
 
Coiled-coils are an important structural motif involved in a diverse array of 
important protein interactions. They are a highly adaptable class of proteins both in terms 
of structure and function, and they are prevalent in all domains of life indicating the 
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evolutionary success of the motif. Coiled-coil domains are predicted in approximately 
10% of eukaryotic proteins, and less than 5% in prokaryotes (60, 61). It has been 
suggested that the expansion of coiled coils and their interactions underlies metazoan cell 
and tissue structure variation (62). 
The coiled-coil typically consists of two or more α-helices wrapped around one 
another. Coiled-coils are characterized by amino acid sequences forming a heptad repeat 
pattern. In this sequence, the first and fourth residues are hydrophobic, and residues in the 
fifth and seventh position are primarily charged or polar (63). Coiled-coil segments may 
be unfolded in monomeric form and then fold during interaction with a binding partner 
(64). A two-state transition often describes the folding and unfolding of coiled coils, i.e., 
unfolded peptide monomers cooperatively fold to form coiled-coil dimers or oligomers 
(63). 
Despite the simplicity of the architecture, the coiled-coil motif exhibits considerable 
variation in terms of stability and dynamics. These characteristics may in turn determine 
the ability of coiled-coil domains to evolve; poorly packed and disordered proteins may 
show a high ability to evolve. Protein stability may then be tailored to the biological 
function. Coiled coils participate in numerous cellular functions and the simple yet 
dynamic nature of their structure may prompt binding with various partners and the 
formation of multiple complexes. However, binding partner selection appears to be an 
intricate process during which evolution may fine-tune each protein so as to enhance 
binding and allow for new biological functions, or the emergence of novel proteins (65). 
Comparisons of sequence and structure provide insight regarding evolutionary 
relationships between proteins. The relatively simple repeating sequence of the coiled 
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coil motif suggests that it likely emerged multiple times during protein evolution. Small 
evolutionary changes in sequence and structure may result in large changes in binding 
dynamics, and thus biological function. The paths leading to novel functions likely 
proceed through states in which isoforms and relatively unstable structures emerge and 
coexist (65); one or more of these forms may perform new tasks beneficial for the 
organism resulting in the evolution of a new biological function. This scenario might very 
well be represented by the subtle changes over time in the coiled coil regions of p66α and 
MBD2 and MBD3. 
The role of DNA methylation and methyl-cytosine binding domains has clearly 
changed during the course of metazoan evolution. The ancestral MBD may have played a 
role in gene regulation or modifying chromatin structure, but the expansion of the 
methylation landscape in vertebrate genomes created an environment in which new 
dynamic properties of regulatory proteins were required; expansion of the first MBD’s 
functional role may have occurred concomitant to changes in the DNA methylome.  Of 
course, it has been argued also that the methyl-CpG binding proteins provided both 
greater transcriptional control and protection against mutation, and thereby contributed to 
the global expansion of methylated DNA within the evolving vertebrate genome (3). 
Such contrasting arguments remain to be resolved. Thus, continued study of MBDs 
across the animal kingdom will provide further detail of the changing role of DNA 
methylation and gene regulation in animal evolution.  
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Chapter 2- Probing the Dynamic Distribution of Bound States 
for Methyl-cytosine Binding Domains on DNA 
 
2.1 ABSTRACT   
Although highly homologous to other methylcytosine binding domain (MBD) 
proteins, MBD3 does not selectively bind methylated DNA and thus, the functional role 
of MBD3 remains in question. To explore the structural basis of its binding properties 
and potential function, we characterized the solution structure and binding distribution of 
the MBD3 MBD on hydroxymethylated, methylated and unmethylated DNA. The overall 
fold of this domain is very similar to other MBDs, yet a key loop involved in DNA 
binding is more disordered than previously observed. Specific recognition of methylated 
DNA constrains the structure of this loop and results in large chemical shift changes in 
NMR spectra. Based on these spectral changes, we show that MBD3 preferentially 
localizes to methylated and, to a lesser degree, unmethylated cytosine-guanosine 
dinucleotides (CpGs), yet does not distinguish between hydroxymethylated and 
unmethylated sites. Measuring residual dipolar couplings (RDCs) for the different bound 
states clearly shows that the MBD3 structure does not change between methylation 
specific and non-specific binding modes. Furthermore, RDCs measured for MBD3 bound 
to methylated DNA can be described by a linear combination of those for the methylation 
and non-specific binding modes, confirming the preferential localization to methylated 
sites. The highly homologous MBD2 protein shows similar but much stronger 
localization to methylated as well as unmethylated CpGs. Together, these data establish 
the structural basis for the relative distribution of MBD2 and MBD3 on genomic DNA 
and their observed occupancy at active and inactive CpG-rich promoters. 
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2.2 INTRODUCTION 
 
The mammalian methylcytosine binding domain proteins (MeCP2 and MBD1-4) 
selectively bind symmetrically methylated CpGs through a common methylcytosine 
binding domain (MBD)(1) and likely arose from a gene duplication event of a single 
common ancestral protein (MBD2/3)(2). The preference of MBD2 for methylated DNA 
has been retained in both invertebrates and vertebrates; (3) however, the highly 
homologous MBD3 shows little to no preference for methylated DNA as a result of key 
differences in amino acids critical for DNA contact within the MBD (4, 5). Both proteins 
recruit a nucleosome remodeling and deacetylase (NuRD) complex (6) but in a mutually 
exclusive manner (7). The MBD2-NuRD complex has been specifically shown to 
promote methylation-dependent gene silencing and represents a potential therapeutic 
target for gene reactivation, (6, 8-13) while the function of the MBD3-NuRD complex 
has not been clearly delineated. 
A recent study showed that MBD3 co-localizes with Tet1 and suggested 
preferential binding to hydroxymethylated CpGs (hmCpG) (14). Subsequent experiments, 
however, failed to show a binding affinity preference for hmCpG (15), but instead found 
that both MBD2 and MBD3 preferentially localize to transcriptional start sites with CGIs 
(16, 17). MBD2 predominates at methylated CGIs and the associated genes show reduced 
expression, while MBD3 appears to favor transcriptional start sites with unmethylated 
CGIs and is enriched at active promoters (16). 
To help elucidate the structural differences between MBD2 and MBD3 and evaluate 
the recently proposed hydroxymethylation selectivity, (14) we determined the structure of 
MBD3 bound to DNA containing a single hmCpG dinucleotide. We observed that MBD3 
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adopts a very similar structure to that of MBD2. A critical loop connecting two anti-
parallel β strands is less well defined in MBD3, but otherwise the two structures are 
nearly identical. Furthermore, we show that MBD3 does not specifically recognize 
hmCpG, but chemical shift analysis indicates that MBD3 binds differently to mCpG and 
spends a significant proportion of time on methylated sites. Occupancy depends on the 
number of unmethylated sites available and MBD3 demonstrates chemical shift 
averaging indicative of fast exchange between the methylated and non- specific binding 
modes.  
Residual dipolar coupling (RDC) analysis confirms our findings by showing that 
MBD3 preferentially localizes to mCpG sites and that MBD3 adopts a very similar 
structure on mCpG, CpG, and hmCpG DNA. As expected MBD2 shows a strong 
preference for mCpG sites, exclusively localizing to the mCpG dinucleotide. We also 
find that MBD2 localization is influenced by unmethylated CpG density, and that MBD2 
shows an unanticipated additional weak localization to hmCpG. 
Taken together this information leads to a model in which the methylation 
specificity and occupancy of an MBD can be titrated by single amino acid substitutions. 
Importantly, the tendency to localize on a specific site does not necessarily translate into 
a global binding affinity preference. These data are consistent with recent studies 
showing that both MBD2 and MBD3 localize to transcription start sites associated with 
CGIs (16, 17, 31). The ability to condense chromatin and silence transcription at or near 
methylated CGIs reflects MBD2 high affinity and stable occupancy of mCpG sites. 
Hence, we propose that MBD3 evolved, at least in part, to counterbalance MBD2 on 
unmethylated CGIs. The presence of MBD3 at unmethylated CGIs could modify the 
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distribution of MBD2 and potentially mitigate strong silencing by the high- affinity, more 
strongly localizing MBD2 protein, thereby preserving bivalency with respect to 
transcription. 
 
2.2.1 Use of NMR spectroscopy 
Some of the key ideas of nuclear magnetic resonance (NMR) spectroscopy are 
discussed in this section. It should be noted that the description of NMR spectroscopy 
presented is not meant to offer a complete depiction of the process and the theory 
underlying its performance. The purpose of the material here is to provide some 
background that may allow the reader to better understand the NMR-derived data 
presented later in this chapter.   
 NMR spectroscopy represents a powerful tool for studying how biology works at 
the molecular level. The process provides access to information useful for studying 
several aspects of chemical biology on the atomic level, including: analysis of protein 
structure, protein folding dynamics, and protein-protein and protein-DNA interactions. 
Thus, NMR spectroscopy enhances our capacity to collect structural data from which 
atomic-level functional understanding can be developed. 
 
2.2.1.1 Key principles 
In quantum-mechanical theory, each atomic nucleus possesses a property known as 
spin. From a classical viewpoint, this attribute allows each nucleus to behave in a manner 
similar to a spinning top toy or a gyroscope. On a smooth surface a top spins freely about 
its main axis while also moving in a circular motion (i.e., precession) dictated by the 
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torque exerted by its weight. Figure 2.1, left image, represents this motion. In the case of 
the nucleus, the torque on the nuclear spin results from interaction with the magnetic 
field. The spinning top analogy is useful for explaining how the magnetic moments of the 
nuclei couple with an applied radiofrequency (rf) pulse and ultimately lead to a 
macroscopic oscillating magnetic field detected by a coil within the spectrometer.	  	   
 
 
 
 
 
 
 
 
 
In a sample of spin 1/2 nuclei in an external magnetic field, two populations will 
emerge, one aligned with the field, and the other against. Nuclei oriented against the 
direction of an external magnetic field (designated -1/2) associate with a higher energy 
spin state, and those oriented with the direction of the field (+1/2) associate with lower 
energy (figure 2.1, right; figure 2.2A). The energy difference between the two spin states 
is always very small but nevertheless dependent on the strength of the external magnetic 
field. That is, when the external field strength is zero, the two spin states are equally 
populated and have the same energy.  When the field strength increases, the spin states 
diverge creating two distinct energy states. The ability to use strong magnets to 
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Figure 2.1: Nuclear spin. Left: a depiction of a spinning top toy. Right: a 
depiction of the two different allowed spin states of a 1H nucleus.  
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manipulate these populations of nuclei serves as the basis of NMR spectroscopy.  
 
 
 
 
 
  
 
 
 
 
Even in a magnetic field of very high strength, the energy difference between two 
spin states is very small and is represented in MHz with the actual energy difference 
again depending on the strength of the field and the nucleus involved. For the nuclei used 
in this body of work, primarily hydrogen (1H- proton) and nitrogen-15 (15N) nuclei, the 
energy difference between their spin states depends upon their respective magnetic 
moments. Irradiation of the sample with rf energy that matches the energy difference 
between the two spin states may transition some of the nuclei in the lower energy state to 
the higher energy state, and vice-versa, at room temperature. Since excitation energy 
applied to the sample falls within the radiofrequency range, NMR spectroscopy 
represents a very mild manner by which molecular structure may be probed. 
Although magnetic fields are uniformly applied to samples, the actual magnetic 
field experienced at the level of the nucleus depends upon several environmental factors; 
Figure 2.2: A) Energy versus magnetic field plot. B) Depiction of the magnetic dipole.  
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scanning the energy absorption by nuclei provides highly useful information regarding 
the chemical environment in which nuclei exist in a sample. However, the absorption of 
radiation is very difficult to detect since the difference between the populations in the two 
spin states is very small, as discussed above. To heighten the ability to detect absorption 
of radiation, relatively high concentrations of the nuclei observed must be present. 
Detection sensitivity depends on the characteristics of the nucleus observed, the 
abundance of the nucleus, and the energy difference in the two spin states. Thus, stronger 
magnets that produce larger magnetic fields are in continuous development. 
Unfortunately, carbon-12, which is highly abundant, produces no signal during NMR 
analysis. This is also the case for nitrogen-14. On the other hand, carbon-13 and nitrogen-
15 isotopes will produce signal, hence their use in NMR studies is highly valuable. 
Hydrogen nuclei are the most sensitive to NMR methods and the most extensive 
experimentation has been carried out using proton NMR. One might think that since all 
protons have the same magnetic moment, then all hydrogen nuclei will behave the same 
in a magnetic field. That is, hydrogen atoms might be expected to emit resonance signals 
at the same field versus frequency values. Fortunately, this is far from true. Protons in 
different compounds respond very differently in NMR experiments. The reason for the 
difference in behavior lies outside of the nucleus, in the electron cloud.  
 
2.2.1.2 Shielding and Chemical shifts  
As charged particles, electrons will respond to an external field by moving in a 
manner that generates a secondary magnetic field opposing the stronger external field. It 
has been shown that naked protons resonate at lower field strength than those hydrogen 
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nuclei involved in covalent bonds. This behavior results from the secondary field, 
generated by the movement of electrons, which shields the proton nucleus from the 
applied external field. Thus, the magnetic field strength must increase in order to bring 
about resonance (absorption of radiofrequency energy).  
The ability to achieve excitement and resonance depends upon the degree of 
shielding exerted by surrounding electrons. The degree of shielding experienced by a 
proton is determined by the electronegativity of its covalent binding partner and of 
surrounding nuclei. For example, a hydrogen atom covalently bound to a bromine atom 
will be more de-shielded than one bound to a carbon atom, since the electronegativity 
difference between hydrogen and carbon is small. Further, a hydrogen atom in a chemical 
environment where it is both covalently bound to an atom with higher electronegativity 
and involved in an intermolecular interaction with a different atom of higher 
electronegativity (e.g. a hydrogen bond), will be further de-shielded; the proton nucleus 
will resonate at a higher frequency than that of a fully shielded nucleus.  
The usefulness of NMR results from the interaction of nuclei with surrounding 
electrons and other nuclei in the molecule and sample solution. As mentioned earlier, 
high electron density around a nucleus produces a field that opposes the external field. 
The resonance frequency associated with this phenomenon scales with the magnetic field 
strength. Hence if we normalize by field strength, the chemical shift will be the same 
across spectrometers. Chemical shifts due to changes in chemical environments are taken 
into account by expressing the shift as a relative change in frequency with respect to the 
reference compound. To produce an unambiguous signal location, frequency differences 
(in Hz) between the reference signal and all other signals must be corrected by dividing 
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those differences by the frequency of the spectrometer (in MHz). Since this calculation 
itself will produce very small values, the quotient is multiplied by one million. The 
resulting value is known as the chemical shift (σ) and is reported in parts-per-million, 
ppm, a unit that reflects the normalization by the MHz field strength as described 
previously. 
The chemical shift depends on the orientation of the sample to the magnetic field. 
Since the samples used in our studies are in solution, the rapid tumbling of the molecules 
leads to averaging of the chemical shifts thereby producing sharp resonance peaks. For 
large molecules and molecular complexes, the rate of tumbling is slower which broadens 
the resonance peaks observed and obscures the spectrum. Special conditions are met for 
solid or semi-solid environments so as to collect spectra, as will be presented later in the 
residual dipolar coupling discussion.  
Again, high electron density increases shielding effect, such that the resonance 
frequency is lower. The result is an upfield shift and a decrease in the chemical shift 
towards the reference. Conversely, low electron density causes a downfield shift and an 
increase in σ. Although chemical shift data is highly useful for examining protein 
structure, chemical shift information is itself insufficient to determine protein structure.  
The magnetic field range representing the resonances of protons in different 
chemical environments is very small (see figure 2.3). Detecting a ppm difference can be 
described as equivalent to detecting a one-millimeter difference in one-kilometer 
distances. Current application of NMR involves strong magnets that allow observation of 
proton resonances within most organic compounds between 0-14 ppm. Strong magnetic 
fields and high sensitivity may produce signals that are distinct and well separated, signal 
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detection and assignment in an unambiguous manner is very difficult without a numerical 
locator. To overcome this issue special reference compounds are added to samples so as 
to detect individual signals in a spectrum relative to the signal of the reference substance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The frequency dependence of the absorption can be transformed into a time 
dependence and vice-versa through Fourier transformation. In practice, a timed 
radiofrequency pulse is applied to a sample to excite the observed nuclei and then watch 
those nuclei return to their equilibrium population distributions in the magnetic field 
(aligned with or against the external field). During the return to equilibrium, known as the 
free induction decay (FID), an oscillating signal is produced which then decays over time 
Figure 2.3: Magnetic field range representing the resonances of protons in 
different chemical environments. 
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but not before a measurable oscillating current is generated in a coil of wire. The time 
domain data can be transformed into a frequency spectrum (figure 2.4) wherein the rate 
of decay determines the peak width and the oscillation determines the frequency of the 
peak. Multiple FIDS can be added to produce peaks with more signal-to-noise than a 
single FID. 
 
 
 
2.2.1.3 Relaxation times and chemical exchange 
During an experiment a rf pulse orients nuclei in a specific direction, with 
precession about the direction of the external field.  When the pulse ends, the nuclei in 
the sample will return to the equilibrium conditions and populations (spin states) 
associated with their environment. The rate at which each spin returns to its equilibrium 
conditions depends on interactions with its neighbors (surrounding nuclear spins). This 
rate also depends on fluctuations in the fields experienced as molecules tumble.  
If a proton has a different chemical shift for two different states (represented by the 
!
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Figure 2.4: Free induction decay of nuclei in a magnetic field. 
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following simple expression: A↔B) then the proton resonates at two different 
frequencies. If the rate of exchange between the two states (chemical exchange) is very 
slow, then two distinct, sharp peaks will be observed in the NMR spectrum. Conversely, 
if the exchange occurs very rapidly, states A and B will interconvert repeatedly during 
the test, and the two frequencies will average, thus causing observance of a single sharp 
peak located at the weighted average between states A and B. This phenomenon indicates 
the fraction of time spent in state A versus B; if the weighted average is closer to A than 
B, then occupancy in state A is higher than that of state B and a peak will be observed 
closer to the peak associated with state A. During intermediate chemical exchange, the 
two lines observed in a slow exchange scenario will appear as if they had broadened and 
coalesced into a single broad peak. However, even in the fast exchange regime, if a large 
frequency difference exists between the two states, peak broadening may occur similar to 
that of intermediate exchange. 
 
2.2.1.4 Two-dimensional (2D) NMR 
The preceding information mostly pertained to acquisition of a spectrum for a 
specific nucleus (one-dimensional NMR- 1D NMR) by applying a frequency pulse and 
analyzing the frequencies associated with a FID. In order to collect more accurate 
structural information about molecules, utilizing multidimensional NMR becomes 
necessary, whereby “cross-peaks” linking two resonances are identified. For the purposes 
of the studies presented in this chapter, 1H and 15N resonances are analyzed, through 
space and through chemical bonds so as to identify the spatial relationship between those 
nuclei. 
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Whereas 1D NMR involves application of a single pulse, followed by FID and data 
collection, the multidimensional process begins with application of several 
radiofrequency pulses and time delays after which a FID is collected. The type of 
experiment determines the number and length of the pulses and delays. This experiment 
is repeatedly carried out and the signal collected is added. For the purpose of this 
explanation, the qualitative details of the pulses and delays will be excluded. 
Ultimately, the collected data for the 1H and 15N resonances undergoes Fourier 
transformation and becomes represented in a two-dimensional plot where the frequencies 
for the two nuclei are plotted against one another. Nuclear spins of different non-bonded 
nuclei (usually 1H-1H) may be measured through space as a result of interactions 
(coherence transfer) between magnetic dipoles of the two nuclei. The through-space 
interaction of magnetic dipoles is known as the Nuclear Overhauser Effect (NOE) and 
analysis of the interactions is termed Nuclear Overhauser Effect SpectroscopY (NOESY). 
NOE interaction between two magnetic dipoles varies as the inverse sixth power of the 
distance between the two dipoles. Hence, only interacting nuclei very close to one 
another (within approximately 5Å) will give rise to measurable NOEs.  
 Another informative process involves detection only of pairs on covalently linked 
1H and 15N nuclei and is known as heteronuclear single quantum coherence (HSQC). 
Each peak on an HSQC contour map represents a pair of covalently bound 1H-15N nuclei; 
by convention, the x-axis represents the proton resonance frequency and the y-axis 
represents the 15N. HSQC spectra provide highly informative data for assigning observed 
resonances to specific amino acids in a protein structure, except proline, which has no 
backbone N-H. HSQCs can provide further detail of protein structure from additional 
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resonances provided by side-chains containing amides. 
Structural determination from NMR data involves assigning resonances to specific 
nuclei within the structure via analysis of 1H-15N (or other) HSQCs and sequential 1H-1H 
NOEs. A three-dimensional model of the structure may be calculated through the use of 
numerous constraints provided by distance information from NOEs and dihedral angle 
information. The constraint information is then converted to a family of similar structures 
that satisfy the experimental constraints. 
   
2.2.1.5 Residual dipolar coupling 
Protein structure determination has traditionally relied on the 1H-1H NOE and 
various other constraints. Chemical shift analyses offer information pertaining to local 
constraints on dihedral bond angles, whereas NOE data can relate atoms of a protein far 
apart in the amino acid sequence, but close in space.  Structural calculation often requires 
a large amount of NOE data, but nevertheless can produce precise structural detail. In 
certain situations, though, a lack of NOE cross-peaks reduces the ability to determine the 
relative orientation of protein domains (e.g., non-globular or multi-domain proteins, 
intermolecular complexes between proteins and between protein and DNA). Thus, a 
demand exists for techniques that provide both local and long-range structural 
information. 
Interactions between pairs of magnetic dipoles in the presence of an external 
magnetic field are referred to as dipolar couplings. This type of interaction is similar in 
nature to a through-bond (scalar) interaction between nuclei, but unlike a scalar 
interaction, dipolar couplings average to zero through normal rotational tumbling of 
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molecules in solution. This phenomenon cannot be observed unless the rotational 
movement of molecules in solution becomes restricted to a preferred orientation with 
respect to the magnetic field. Introducing a weak degree of molecular alignment allows 
for measurement of the residual 1H-15N dipolar-coupling interaction whose magnitude 
depends on the degree of alignment and the angle formed between the internuclear vector 
and the magnetic field. Hence, in this situation these couplings are referred to as residual 
dipolar couplings (RDCs). 
The information provided by RDCs directly relates to the distance between nuclei 
and their relative orientation regarding a molecular reference frame defined by the nature 
of the molecular alignment (see figure 2.5). Achievement of a weak degree of alignment 
is critical to the acquisition of this information since the dipolar coupling interaction is 
very strong; the effect can produce peaks wider than the spectrum normally collected. But 
if only a small degree of alignment is introduced, then this effect shows up as a very 
small chemical shift change (i.e., within a few Hertz) that compares to an otherwise very 
sharp spectrum from a protein tumbling freely in solution. Therefore, the nature of the 
alignment medium must allow for tuning, so that an appropriate degree of solute 
alignment can be achieved. The alignment medium must also be relatively stable in 
varying experimental conditions while minimizing adverse solute interactions that might 
prompt unfavorable alignment conditions (e.g., interactions that adversely affect 
rotational tumbling, thereby altering relaxation times).  
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Though several forms of alignment media are available, the filamentous 
bacteriophage particle, Pf1, was used as the alignment medium for the work described in 
this chapter. The bacteriophage particle will align in a preferred orientation in a magnetic 
field and influence the partial orientation of other solute molecules. Pf1 is highly 
negatively charged and can, therefore, electrostatically interact with molecules that have 
positively charged surface regions, as is the case with MBD2 and MBD3. For our studies, 
though, alignment was carried out in the presence of DNA; the DNA is very negatively 
charged and dominates the protein interaction. Hence, the repulsive interaction between 
the DNA and Pf1 drives the partial alignment. Tuning the concentration of phage to 
achieve sufficient alignment becomes necessary wherein the virus particles adopt a 
preferred orientation in the magnetic field. In this preferred orientation the particles point 
in the same direction with respect to the direction of the external magnetic field. Other 
molecules in solution will then adopt an orientation in response to that of the phage 
particles.  
In practice, RDC analysis provides detail of the orientation of dipolar coupling 
Figure 2.5: Relative orientation of nuclei in a magnetic field regarding a molecular 
reference frame defined by the nature of the molecular alignment. 
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vectors, and thus the chemical bond orientation, in a protein that connect atoms 
experiencing homonuclear (1H-1H) and heteronuclear (1H-15N, CαHα, CαC’, C’N) 
dipolar coupling interactions. For this body of work, coupling was measured between the 
amide 1H and 15N atoms so as to measure the angle between the amide bond and the 
alignment tensor, and thus, the relative orientations of NH bonds with respect to one 
another (figure 2.6). The axis system created within the magnetic field is represented by 
Axx, Ayy, and Azz in figure 2.5 and Sxx, Syy, and Szz in figure 2.6. The angles displayed in the 
figure define the orientation of the vector with respect to the magnetic field. The NMR 
pulse program most commonly used to measure the one-bond amide dipolar coupling 
represents a modification of the 15N-HSQC. In this type of modified HSQC, the magnetic 
dipole coupling between the 1H and 15N is allowed to evolve as the 15N chemical shift is 
observed. Measurement of the amide dipole coupling depends, in part, on the distance 
between the bonded nitrogen and hydrogen atoms.  Since this distance is known, the 
RDC measurement can be used to establish the angle between the N-H bond and the 
alignment tensor, which then identifies the relative orientations of the amide bonds with 
respect to each other, as seen in figure 2.6.   
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Again, the orientation of the molecular axis system in the magnetic field along with 
the known distance between the two atoms can be used to define the orientation of the 
bond vector in that axis system. As amino acids are sequentially assigned, the bond 
vectors are sequentially identified in a manner that allows for structural refinement. Aside 
from structural refinement, RDC analysis can be used to identify amino acid residues that 
experience conformational exchange, collect data on binding orientation of ligands in 
complex with protein, and determine the global fold of proteins despite few NOEs 
collected (32). 
RDCs can be used to both validate and improve existing structure quality. 
Regarding the latter, RDC measurement can reduce the number of ensemble structures 
that satisfy all experimental restraints and allow for determination of more accurate 
structures, especially when few NOEs are available. For RDC-derived structures, the Q 
factor represents structure quality. That is, the agreement between the calculated structure 
and the experimental data; in this sense the Q factor is analogous to the R factor used in 
Figure 2.6: Orientation of two dipolar coupling vectors in a 
protein segment and the axis system in a magnetic field.  
. 
Dipolar couplings as a probe of molecular dynamics and structure in solution Tolman    533
employed. For example, purple membrane suspensions
[7••,8] induce alignment largely through electrostatic inter-
actions, whereas uncharged bicelles exert their influence
through a steric mechanism. When the mechanism is purely
steric, it is now possible to predict how a molecule will
align on the basis of its shape [12•]. The measurement of
complementary sets of RDCs by using media with different
aligning potentials is highly advantageous. This is
because the interpretation of a single measured RDC is
ambiguous; aside from invariance to inversion, allowed
orientations for internuclear vectors span a continuous
range of angles. It has been shown that the titration of
bicelles with a charged amphiphile (cetyltrimethylammo-
nium bromide) can alter the alignment sufficiently such
that, in many cases, only a twofold ambiguity remains for
the orientation of a single peptide plane [13]. As illustrated
by Al-Hashimi et al. [14], this ambiguity can be completely
removed for nonplanar molecular fragments with the use
of a second alignment medium.
The alignment media mentioned thus far share in common
the fact that their ordering is established relative to the
direction of the static magnetic field. A separate class of
media might be distinguished by the fact that they consti-
tute an anisotropic environment that is independent of the
magnetic field direction. This has been accomplished by
applying mechanical stress to polyacrylamide gels [15•,16•]
or by immobilizing purple membrane fragments within a
gel [16•]. As noted by Tycko et al. [15•], this suggests the
interesting possibility of producing a biaxial variety of this
sort of medium and then collecting complementary RDC
data simply by varying the angle of the sample with
respect to the magnetic field.
Outlook for de novo structure determination
by NMR
It is clear that the use of RDCs can improve the quality of
structures determined by NMR [17]. In fact, their use is
now so widespread that it is only possible to address a cross
section of applications here. Many of these have recently
been reviewed [1] and discussion here will foc s on more
recent applications in which RDCs played a pivotal role.
Studies of nucleic acids have traditionally suffered from
inadequate densities of NOEs, with consequent difficul-
ties in establishing global structures with meaningful
accuracy and precision. Despite anticipation of the utility
of RDCs for defining global aspects of nucleic acid
structure [2,18], only recently have applications appeared
that demonstrate this experimentally. The first to be
reported was a high-resolution NMR structure of the
Dickerson dodecamer in which a large number of RDCs
were measured [19••]. Most structural parameters were
well determined from the experimental data, with the final
structure conforming to a very regular B-form helix. More
recently, the structure of a dodecameric DNA A-tract
sequence has been determined with the inclusion of RDC
data. The structure exhibits an over ll bend of 19°, in
agreement with observations in gel mobility studies [20].
Like nucleic acids, studies of multiple-domain proteins
can be complicated by difficulties in establishing the global
relationship between elements. Structure redetermina-
tions of the transcription factor IIIA–DNA complex [21]
and hen lysozyme [22], both carried out with the benefit of
inclusion of RDCs, exhibited clear improvements in the
ability to establish relative domain orientation.
There have also been applications in which RDCs have
helped reduce the reliance on NOEs in structure determi-
nation. Aside from gains in accuracy, this can substantially
reduce the amount of time needed to determine a struc-
ture. This is because an often extensive set of sidechain
assignments is required in order to obtain sufficient num-
bers of critical long-range NOEs. The idea is therefore to
shift the burden of fold determination from long-range
NOEs to easily measured RDCs. An example of this is the
determination of the 81-residue protein DinI [23]. A heavy
atom backbone precision of 0.17 Å was achieved using only
140 long-range NOEs and 333 RDCs collected in two
different alignment media. For NMR studies of large
proteins, the requirement that the protein be at least
partially deuterated in order to lengthen transverse spin
relaxation times often reduces the number of observable
NOEs to unacceptably low levels. Supplementary
Figure 1
For directly bonded nuclei, observed RDCs depend only on the
orientation of internuclear vectors rela ive to a common coordinate
system fixed to the molecule. Although omitted for clarity, dipolar
couplings also depend on the azimuth angle in the x–y plane. The
positioning of the Cartesian axes is determined by the nature of the
ordering (or alignment) of the molecule. Thus, by using a different
alignment medium, these axes may be repositioned, allowing the
acquisition of RDCs essentially from a different perspective.
Current Opinion in Structural Biology
N H
N
H
Szz
Sxx
Syy
θ1
θ2
	   43	  
x-ray crystallography. Values of approximately 25% represent high-resolution structural 
refinement. 
 
2.3 EXPERIMENTAL PROCEDURES 
 
2.3.1 Purification of proteins and DNA:  
The methylcytosine-binding domain of MBD3 (amino acid residues 1-70) was 
cloned, expressed and purified as previously described for cMBD2 (18). 17-bp and 27-bp 
complementary oligonucleotides (Table 1) were purchased (Integrated DNA 
Technologies), annealed and purified as previously described (18). The sequences were 
derived from the p16INK4a promoter known to be a native target sequence for MBD2 (5). 
 
2.3.2 NMR spectroscopy:  
Purified protein was combined with 10% excess purified dsDNA and buffer 
exchanged into 10 mM NaPO4, pH 6.5, 1mM dithiothreitol, 10% 2H2O and 0.02% 
sodium azide and concentrated to 0.2-1.0 mM. NMR spectra from standard experiments 
for resonance assignments, distance and torsional angle restraints were collected on a 
Bruker Avance III 700 MHz instrument. Data were processed using NMRPipe (19) and 
analyzed with CcpNmr (20). Residual dipolar couplings were measured for complexes 
containing 2H, 13C, 15N  labeled protein using standard IPAP experiments and samples 
aligned by adding ~12mg/mL Pf1 bacteriophage (Asla Biotech, Ltd.). For each aligned 
sample, a 1D 2H spectrum of 2H2O was collected and the deuterium quadrupole splitting 
measured. When comparing RDC values between samples, the observed RDC values 
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were normalized to an effective deuterium quadrupole splitting of 10 Hz. 
 
2.3.3 Structure Calculations: 
 The structure of the MBD3 MBD was calculated by simulated annealing as 
implemented in the Xplor-NIH software package (21) and based on NOE derived 
distance constraints, torsion angle restraints, and residual dipolar couplings as well as a 
torsion angle database potential of mean force (22) and a quartic van der Waals repulsion 
term for non- bonded contacts (23). Backbone torsional angle restraints were derived 
from chemical shifts using the TALOS+ software (24) and hydrogen bond distance and 
angle restraints were introduced based on backbone torsional angles and characteristic 
NOE patterns. 
 
2.3.4 Binding affinity:  
Binding affinities were determined by surface plasmon resonance analysis on a 
Biacore T100 system (GE Healthcare) as described previously (18). The binding affinity 
was determined from steady state analysis of the SPR relative response at varying 
concentrations of protein. As previously shown, the maximum steady state response 
(Rmax) in SPR depends on stoichiometry (n) of binding (25). Prior to fitting, the steady 
state response at each protein concentration (RA) was normalized (Rnorm) to the total DNA 
immobilized (Rl) and molecular weights of the DNA and protein (MWL and MWA, 
respectively). 
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Final data analysis, plotting, and curve fitting were performed with pro Fit software 
(QuantumSoft). 
 
2.4 RESULTS 
 
2.4.1 Solution structure of the MBD3 MBD is nearly identical to that of MBD2.  
We determined the solution structure of the MBD from MBD3 (amino acids 1-70) 
bound to a 17-bp dsDNA with a central hydroxymethylated CpG dinucleotide. The 
structure was calculated based on 528 NOE derived distance constraints, 120 dihedral 
angle restraints, and 53 residual dipolar coupling restraints (Table 2.1). The overall 
protein structure is well defined (Fig. 2.7A-B) with average pairwise root mean square 
deviations (RMSD) of 0.7±0.1 Å (backbone) and 1.2±0.1 Å (all heavy atoms) for ordered 
regions (residues 6-23,34-71). As expected, the fold is very similar to that of chicken 
MBD2 (cMBD2; RMSD=2.0±0.1 Å) for the same ordered regions (Fig. 2.7D) (18). 
As with all MBD proteins studied to date, the topology of the MBD comprises a 
four-stranded β-sheet followed by a single α-helix and a C-terminal loop. The central two 
strands of the β-sheet (β2 and β3) form a long finger-like projection that can extend down 
and across the major groove of DNA to make base specific contacts. The most notable 
difference between the cMBD2 and MBD3 structures is that the loop connecting the long 
fingerlike projection is not as well ordered in MBD3 (residues 24-33, Fig. 2.7A,C) with 
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dipolar couplings were measured for complexes 
containing 2H,13C,15N labeled protein using 
standard IPAP experiments and samples aligned 
by adding ~12mg/mL pf1 bacteriophage (Asla 
Biotech, Ltd.).  For each aligned sample, a 1D 2H 
spectrum of 2H2O was collected and the deuterium 
quadrupole splitting measured.  When comparing 
RDC values between samples, the observed RDC 
values were normalized to an effective deuterium 
quadrupole splitting of 10 Hz. 
Structure Calculations: The structure of the 
MBD3 MBD was calculated by simulated 
annealing as implemented in the Xplor-NIH 
software package (21) and based on NOE derived 
distance constraints, torsion angle restraints, and 
residual dipolar couplings as well as a torsion 
angle database potential of mean force (22) and a 
quartic van der Waals repulsion term for non-
bonded contacts.(23)   Backbone torsional angle 
restraints were derived from chemical shifts using 
the TALOS+ software (24) and hydrogen bond 
distance and angle restraints were introduced 
based on backbone torsional angles and 
characteristic NOE patterns. 
Binding affinity: Binding affinities were 
determined by surface plasmon resonance analysis 
on a Biacore T100 system (GE Healthcare) as 
described previously.(18)  The binding affinity 
was determined from steady state analysis of the 
SPR relative response at varying concentrations of 
protein.  As previously shown, the maximum 
steady state response (Rmax) in SPR depends on 
stoichiometry (n) of binding.(25)    Prior to fitting, 
the steady state response at each protein 
concentration (RA) was normalized (Rnorm) to the 
total DNA immobilized (Rl) and molecular 
weights of the DNA and protein (MWL and MWA, 
respectively). 
 
 
Rnorm =
RA
RL i
MWA
MWL
⎛
⎝⎜
⎞
⎠⎟
  (1) 
Final data analysis, plotting, and curve fitting were 
performed with pro Fit software (QuantumSoft).   
 
RESULTS 
Solution structure of the MBD3 MBD is nearly 
identical to that of MBD2: We determined the 
solution structure of the MBD from MBD3 (amino 
acids 1-70) bound to a 17bp dsDNA with a central 
hydroxymethylated CpG dinucleotide. The 
structure was calculated based on 528 NOE 
derived distance constraints, 120 dihedral angle 
restraints, and 53 residual dipolar coupling 
restraints (Table 2).   The overall protein structure 
is well defined (Fig. 1A-B) with average pairwise 
root mean square deviations (RMSD) of 0.7±0.1 Å 
(backbone) and 1.2±0.1 Å (all heavy atoms) for 
ordered regions (residues 6-23,34-71).   As 
expected, the fold is very similar to that of chicken 
MBD2 (cMBD2; RMSD=2.0±0.1 Å) for the same 
ordered regions (Fig. 1D).(18)   
As with all MBD proteins studied to date, the 
topology of the MBD comprises a four-stranded β-
sheet followed by a single α-helix and a C-
terminal loop.  The central two strands of the β-
sheet (β2 and β3) form a long finger-like 
projection that can extend down and across the 
major groove of DNA to make base specific 
contacts.  The most notable difference between the 
cMBD2 and MBD3 structures is that the loop 
connecting the long fingerlike projection is not as 
well ordered in MBD3 (residues 24-33, Fig. 1A,C) 
with an RMSD of 1.7±0.5 Å (backbone) as 
compared to cMBD2 with an RMSD of 0.9±0.3 Å.  
Residues at the base of this loop form critical 
DNA specific contacts and a hydrogen bond 
network that stabilizes the interaction with the 
methylated CpG dinucleotide (Fig. 1E).  
Predicting backbone order parameters (S2) 
based on chemical shifts using the random coil 
index (RCI) method (24, 26) confirms that this 
loop is less well ordered in MBD3  (Fig. 2).  The 
difference in predicted S2 between complexes and 
shows that residues 24-33 become progressively 
more ordered between the MBD3:hmCpG, 
MBD3:mCpG and cMBD2:mCpG complexes, 
respectively.   Thus in the absence of a 
methylation-specific binding mode, the loop 
connecting the central two β-strands is more 
flexible. 
Filtered intermolecular NOE spectra did not 
contain NOE crosspeaks, which is consistent with 
the observed line broadening for residues at the 
DNA interface and the overall lower affinity of 
MBD3 for DNA and suggests non-specific 
protein-DNA interaction with dynamic exchange 
between binding sites.   Based on subsequent 
analyses that indicate MBD3 preferentially 
localizes to methylated sites, we collected filtered 
NOE spectra for MBD3 bound to methylated 
DNA (mCpG). Likewise, we did not detect any 
intermolecular NOE crosspeaks with methylated 
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an RMSD of 1.7±0.5 Å (backbone) as compared to cMBD2 with an RMSD of 0.9±0.3 Å. 
Residues at the base of this loop form critical DNA specific contacts and a hydrogen 
bond network that stabilizes the interaction with the methylated CpG dinucleotide (Fig. 
2.7E). 
Predicting backbone order parameters (S2) based on chemical shifts using the 
random coil index (RCI) method (24, 26) confirms that this loop is less well ordered in 
MBD3 (Fig. 2.8). The difference in predicted S2 between complexes and shows that 
residues 24-33 become progressively more ordered between the MBD3:hmCpG, 
MBD3:mCpG and cMBD2:mCpG complexes, respectively. Thus in the absence of a 
methylation-specific binding mode, the loop connecting the central two β-strands is more 
flexible. 
Filtered intermolecular NOE spectra did not contain NOE crosspeaks, which is 
consistent with the observed line broadening for residues at the DNA interface and the 
overall lower affinity of MBD3 for DNA and suggests non-specific protein-DNA 
interaction with dynamic exchange between binding sites. Based on subsequent analyses 
that indicate MBD3 preferentially localizes to methylated sites, we collected filtered 
NOE spectra for MBD3 bound to methylated DNA (mCpG). Likewise, we did not detect 
any intermolecular NOE crosspeaks with methylated DNA indicating that MBD3 
exchanges among different binding modes whether on methylated or hydroxymethylated  
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DNA. Given the absence of informative intermolecular NOEs we did not determine a 
solution structure of the protein-DNA complex. Importantly, we noted that chemical 
shifts of MBD3 bound to hmCpG (discussed in detail below) are more similar to MBD3 
on unmethylated DNA than methylated DNA, which led us to compare spectra of MBD3 
on different DNA molecules to probe both methylation-specific and non-specific DNA 
association. 
 
FIGURE 2.7: Solution structure of MBD3 methyl binding domain bound to hydroxymethylated 
DNA. (A) Stereo ribbon diagram (blue) of the MBD3 solution structure is shown for the ensemble of 
twenty calculated structures (PDB ID: 2mb7). The loop connecting β2 and β3 (residues 24-33) is 
highlighted in light blue. (B) Ribbon diagram of the lowest energy solution structure is shown with key 
contact and chemical shift reporter residues depicted in sticks. (C) Per residue root mean standard 
deviation (RMSD) for backbone atoms is plotted for the solution structure ensemble of MBD3 (blue) and 
for the solution structure ensemble of cMBD2 (red) previously reported (PDB ID: 2ky8).(18) (D) The best 
fit protein alignment of the solution structures of cMBD2 (green) and MBD3 (blue) MBD is shown bound 
to the methylated DNA from the cMBD2:dsDNA solution structure (PDB ID: 2ky8). (E) Diagram 
highlighting the cMBD2 hydrogen-bonding network while bound to methylated DNA and with key 
residues depicted as sticks. Structure diagrams were generated using the Pymol program (Delano 
Scientific LLC). 
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2.4.2 MBD3 spends a significant portion of time on methylated sites.  
As first described for MeCP2 (27), and later described for cMBD2, (18) a pair of 
highly conserved arginine residues in MBD proteins form bi-dentate hydrogen bonds 
with the symmetrically opposed guanine bases of an mCpG dinucleotide (Fig. 2.7E). The 
aliphatic portion of each arginine packs against the methyl group of the neighboring 
FIGURE 2.8: Methyl-specific binding mode stabilizes a dynamic loop in MBD3. (A) Ribbon diagram 
of the MBD3 solution structure is shown and colored based on order parameters predicted from chemical 
shift index (S2 – shading from blue to red reflects low to high). (B) The predicted order parameters (S2) 
are plotted for the MBD3:hmCpG (black), MBD3:mCpG (blue dotted), and cMBD2:mCpG (red) 
complexes. (C) Bar plots are shown for the difference in order parameters (ΔS2) between the 
cMBD2:mCpG complex and MBD3:mCpG (black) and MBD3:hmCpG (gray) complexes. The loop 
connecting β2 and β3 (residues 24-33) is highlighted in light yellow in plots (B) and (C). 
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methylcytosine. Given that an unmethylated CpG contains symmetrically opposed 
guanines, we hypothesized that MBDs should still recognize the CpG dinucleotide, but 
with lower affinity. Even though MBD3 binds DNA with lower overall affinity and 
shows less selectivity for methylated DNA, the critical arginine residues are conserved 
and could provide sequence specific recognition of CpG dinucleotides. 
In 15N-HSQC spectra, we noted that several crosspeaks that showed unusual 
chemical shifts for cMBD2:mCpG did not show the same chemical shifts for 
MBD3:hmCpG (Fig. 2.9B). In particular, the 1Hε of R24, which forms a sidechain 
hydrogen bond with D32 and is shifted far downfield (9.5ppm) in cMBD2:mCpG, is only 
shifted to 7.5ppm in MBD3. Likewise, G27 is shifted upfield in 15N to 102ppm in 
cMBD2:mCpG, but not to the same degree in MBD3:hmCpG (105ppm), and finally A30 
is shifted upfield in 1H to 6.8ppm in cMBD2:mCpG but only 7.6ppm in MBD3:hmCpG. 
We hypothesized that these large chemical shift changes reflect a difference 
between methylation-specific and non-specific binding modes. R24 and D32 are 
positioned at the N and C terminus of the poorly structured loop in MBD3, while A30 
and G27 also fall within this same loop. Methylation-specific binding stabilizes the 
R24:D32 H-bond and the loop containing G27 and A30. To test this hypothesis, we 
compared HSQCs for MBD3 bound to a DNA sequence with three CpG dinucleotides in 
which the central CpG is methylated (mCpG), hydroxymethylated (hmCpG), or 
unmethylated (CpG(x3)), as well as similar DNA sequences with only one (CpG(x1)) or 
no CpGs (CpG(x0)) (Table 2.2). 
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Table 2.  NMR and refinement statistics. The number and type of structural constraints as well as the 
final refinement statistics are presented for the solution structure of MBD3 bound to hydroxymethylated 
DNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Pairwise r.m.s. deviation and s.d. from the mean was calculated among 20  
lowest energy (out of 50) refined structures for ordered residues (6-23, 34-71). 
 
 
 
 
 
 
 
 
 
 Protein 
NMR distance and dihedral constraints  
Distance constraints  
    Total NOE 528 
    Intra-residue 102 
    Inter-residue  
      Sequential (|i – j| = 1) 155 
      Medium-range (|i – j| ≤ 4) 111 
      Long-range (|i – j| > 5) 160 
    Hydrogen bonds 32 
Total dihedral angle restraints 120 
    φ 54 
    ψ 54 
    χ1 12 
Total RDCs  
     NH 53 
Q%  
     NH 7.0 
Structure statistics  
Violations (mean and s.d.)  
    Distance constraints (Å)     0.018±0.003 
    Dihedral angle constraints (º) 0.4±0.1 
    Max. dihedral angle violation (º)     4.8 
    Max. distance constraint violation (Å)  0.48 
Deviations from idealized geometry (mean and s.d.)   
    Bond lengths (Å)     0.04±0.01 
    Bond angles (º) 0.69±0.002 
    Impropers (º) 2.01±0.006 
Average pairwise r.m.s. deviation* (Å)      
    Heavy      1.2±0.1 
    Backbone   0.7±0.1 
Ramachandran plot summary for ordered residues  
Most favored regions 92.4% 
Additionally allowed regions 7.4% 
Generously allowed regions 0.2% 
Disallowed regions 0.0% 
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Table 2.1: NMR and refinement statistics. The number and type of structural 
constraints as well as the final refinement statistics are presented for the solution 
structure of MBD3 bound to hydroxymethylated DNA. 	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We found that the chemical shifts of these reporter resonances fall on a line 
between extrema represented by cMBD2:mCpG and MBD3:CpG(x0). Importantly, the 
peak position for each of the reporter resonances falls at the same fractional distance 
between these extrema (Fig. 2.9B), shifting toward the position in the cMBD2:mCpG 
complex as the number of unmethylated CpG sites increases and with the addition of a 
methylated CpG. These observations strongly indicate chemical shift averaging between 
two binding modes (28) reflective of fast exchange between methylation-specific and 
non-sequence specific interaction with DNA. Furthermore, the chemical shift changes are 
consistent with preferential localization at the CpG and mCpG sites. 
Using cMBD2 as representative of the methylation-specific binding mode could 
introduce structural and primary sequence differences that affect observed chemical 
shifts. Therefore, we sought to generate an MBD3 MBD that binds with high selectivity 
for mCpG, which would allow us to evaluate chemical shift changes for more backbone 
resonances with fewer confounding sequence variations. Previous studies have 
established that the lack of mCpG specificity for MBD3 reflects two amino acids (H30 
and F34) that differ from other MBD proteins (K32 and Y36 in cMBD2) (4, 5). We 
introduced the H30K, F34Y double mutation into MBD3 (MBD3KY) and, as expected, 
this mutant bound with higher affinity and selectivity for mCpG comparable to cMBD2 
(Fig. 2.13, Table 2.3). Each of the reporter resonances now show chemical shifts that are 
very similar to those of the cMBD2:mCpG complex confirming that the unique chemical 
shifts do reflect a methylation-specific binding mode. 
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To further explore the chemical shift changes associated with the different binding 
modes, we assigned the backbone resonances (15N, 1H) for MBD3 bound to mCpG or 
CpG(x3) and MBD3KY bound to mCpG. In Figure 3A, the chemical shift distances are 
plotted for backbone resonances between the different complexes. The largest chemical 
shift changes are seen for the poorly structured loop (residues 24-33) when comparing the 
MBD3KY:mCpG and MBD3:mCpG complexes with the MBD3:hmCpG complex. In 
contrast, the 15N-HSQC spectra for the MBD3:hmCpG and MBD3:CpG(x3) complexes 
show nearly identical chemical shifts and spectra (Fig. 2.11A). 
These observations strongly support a binding model in which MBD3 exhibits fast 
exchange between methylation-specific and non-specific binding. Thus the observed 
chemical shift (σobs) reflects a weighted average of the methylation-specific 
(σMBD3(KY):mCpG) and non-specific (σMBD3:CpG(x3)) binding modes, as given by: 
 
where ρm is the fraction in the methylation-specific binding mode. Hence, these chemical 
shifts are a direct measure of the average time spent on the mCpG site. Using eleven 
backbone 1H, 15N resonances that show a clear linear relationship between chemical shift 
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the MBD3KY:mCpG and MBD3:mCpG complexes 
with the MBD3:hmCpG complex.  In contrast, the 
15N-HSQC spectra for the MBD3:hmCpG and 
MBD3:CpG(x3) complexes show nearly identical 
chemical shifts and spectra (Fig. 5A).  
These observations strongly support a binding 
model in which MBD3 exhibits fast exchange 
between methylation-specific and non-specific 
binding. Thus the observed chemical shift (σobs) 
refle ts a weighted average of the methylation-
specific (σMBD3(KY):mCpG) and non-specific 
(σMBD3:CpG(x3)) binding modes, as given by: 
 
 σ obs = ρm iσ MBD3KY :mCPG + (1− ρm ) iσ MBD3:CPG(x3)   (2) 
where ρm is the fraction in the methylation-specific 
binding mode.  Hence, these chemical shifts are a 
direct measure of the average time spent on the 
mCpG site.   Using eleven backbone 1H,15N 
resonances that how a clear linear elationship 
between chemical shift and DNA bound, we find 
that MBD3 spends approximately 43% (±5%) of 
the time on the mCpG site (Fig. 3B).  
 These data further indicate that, despite a lack 
of a strong global binding affinity preference for 
mCpG DNA, MBD3 still spends a significant 
proportion of time on methylated sites. To confirm 
that this finding was not the result of very weak 
binding with chemical shift averaging between 
DNA bound and free MBD3, we compared 
HSQCs for 600µM and 300µM samples of protein 
on DNA.  The peaks for each reporter residue 
show nearly identical chemical shifts at both 
concentrations (Fig. 5B), indicating that the 
observed chemical shift changes of the reporter 
residues were not the result of exchange between 
bound and free states but instead represent 
averaging between different bound states.  The 
observed differences in chemical shift represent 
changes in the binding distribution on DNA, not 
changes in the distribution between bound and free 
states. 
We developed a statistical-mechanical model 
to describe the distribution of MBD3 on 
methylated DNA (Fig. 3C) in which the partition 
function comprises a sum of Boltzmann factors   
(e-E(i)/kT) for methylation-specific and non-specific 
binding modes, ΔE is the difference in energy 
between binding modes and N is the number of 
non-specific sites.  The additional methylation-
specific interactions formed by MBD2 lead to a 
larger ΔE thereby increasing ρm and the relative 
selectivity for mCpG.   Without these interactions, 
MBD3 shows a smaller ΔE, ρm is reduced but still 
non-zero, and MBD3 distributes unevenly between 
mCpGs and unmethylated sites. Figure 3C depicts 
a simplified structural model of this distribution in 
which the MBD3 structure was docked onto the 
17bp DNA fragment at the centrally methylated 
mCpG (red) as well as four “non-specific” binding 
sites (blue).   The statistical model further 
indicates that localizing to an mCpG depends on 
the number of non-specific sites available (N), and 
therefore the length of DNA. We tested this latter 
prediction by comparing chemical shifts for the 
reporter residues of MBD3 on 10, 17, and 27bp 
DNA with a single mCpG (Fig. 3D). Indeed, we 
found that increasing DNA length results in 
chemi al shift changes for G27 and A30 toward 
the unmethylated binding mode. 
Residual dipolar couplings confirm MBD3 
localizes to methylated sites without significant 
conformational change: As an alternative method 
to assess the ensemble of binding modes, we 
measured residual dipolar couplings (1DNH) for 
MBD3 bound to methylated and unmethylated 
DNA as well as for MBD3KY bound to methylated 
DNA.  As can be seen in Figure 4, the observed 
1DNH are similar but not identical between the 
different complexes.  When plotting 1DNH from the 
unmethylated complex against those from wild 
type MBD3 or MBD3KY methylated complexes, 
the data fall off of the line of identity (y=x), as 
highlighted by the red ovals in Figure 4A-B.   
Since the observed residual dipolar couplings 
reflect a weighted average of the different binding 
modes,(29) the 1DNH for each residue (n) of MBD3 
bound to mCpG is a linear combination of 1DNH for 
MBD3 bound to CpG(x3) (non-specific binding 
mode) and 1DNH for MBD3KY bound to mCpG 
(methylation-specific binding mode): 
 
 
 
1DNH ,MBD3:mCpGpred (n) =
ρm i
1DNH ,MBD3KY :mCpG
obs (n)+ (1− ρm ) i 1DNH ,MBD3:CpG(x3)obs (n)
!!(3) 
 
In Eq. (3), ρm is the fraction in the mCpG specific 
binding mode and 1DNH(n) are the residual dipolar 
couplings for each residue in the MBD3:mCpG, 
MBD3:CpG, and MBD3KY:mCpG complexes.  
Fitting the observed 1DNH to Eq. (3) as a function 
of ρm provides the fraction of MBD3 in the 
methylation-specific binding mode.   As shown in 
Fig 4C, the sum of squared residuals (SSR) 
between predicted and observed 1DNH is 
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TABLES 
 
Table 1.  DNA sequences. The length and nucleotide sequences are given for the different 
dsDNA molecules used for MBD2 and MBD3 binding studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Length  (bp) Sequence  
mCpG  17 GAGGCGCT(mC)GGCGGCAG 
hmCpG  17 GAGGCGCT(hmC)GGCGGCAG 
CpG(x3) 17 GAGGCGCTCGGCGGCAG   
CpG(x1) 17 GAGGCCCTCGGGGGCAG 
CpG(x0) 17 GAGGCCCTCTGGGGCAG 
mCpG27 27 GAGCTAGAGCGCT(mC)GGCGGCGCCAGGC 
mCpG10  10 GGAT(mC)GGCTC 
 by guest on December 5, 2013
http://www.jbc.org/
Downloaded from 
Table 2.2: DNA sequences. The length and nucleotide sequences are given for the different 
dsDNA molecules used for MBD2 and MBD3 binding studies. 
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and DNA bound, we find that MBD3 spends approximately 43% (±5%) of the time on 
the mCpG site (Fig. 2.9B). 
These data further indicate that, despite a lack of a strong global binding affinity 
preference for mCpG DNA, MBD3 still spends a significant proportion of time on 
methylated sites. To confirm that this finding was not the result of very weak binding 
with chemical shift averaging between DNA bound and free MBD3, we compared 
HSQCs for 600µM and 300µM samples of protein on DNA. The peaks for each reporter 
residue show nearly identical chemical shifts at both concentrations (Fig. 2.11B), 
indicating that the observed chemical shift changes of the reporter residues were not the 
result of exchange between bound and free states but instead represent averaging between 
different bound states. The observed differences in chemical shift represent changes in 
the binding distribution on DNA, not changes in the distribution between bound and free 
states. 
We developed a statistical-mechanical model to describe the distribution of MBD3 
on methylated DNA (Fig. 2.9C) in which the partition function comprises a sum of 
Boltzmann factors (e-E(i)/kT) for methylation-specific and non-specific binding modes, ΔE 
is the difference in energy between binding modes and N is the number of non-specific 
sites. The additional methylation- specific interactions formed by MBD2 lead to a larger 
ΔE thereby increasing ρm and the relative selectivity for mCpG. Without these 
interactions, MBD3 shows a smaller ΔE, ρm is reduced but still non-zero, and MBD3 
distributes unevenly between mCpGs and unmethylated sites. Figure 2.9C depicts a 
simplified structural model of this distribution in which the MBD3 structure was docked 
onto the 17-bp DNA fragment at the centrally methylated mCpG (red) as well as four 
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“non-specific” binding sites (blue). The statistical model further indicates that localizing 
to a mCpG depends on the number of non-specific sites available (N), and therefore the 
length of DNA. We tested this latter prediction by comparing chemical shifts for the 
reporter residues of MBD3 on 10, 17, and 27-bp DNA with a single mCpG (Fig. 2.9D). 
Indeed, we found that increasing DNA length results in chemical shift changes for G27 
and A30 toward the unmethylated binding mode. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2.9: Preferential localization of MBD3 to mCpG sites. (A) Bar plots show the chemical shift 
distances between MBD3:dsDNA complexes. (B) An overlay of 15N-HSQC spectra are shown for key 
reporter residues of MBD3 bound to CpG(0x), CpG(1x), CpG(3x), mCpG and hmCpG as well as 
MBD3KY and cMBD2 bound to mCpG. (C) The derivation of a simple statistical mechanical model for 
the distribution of MBD3 on mCpG (top) is shown with a mixed rendering diagram (bottom) depicting 
MBD3 docked onto a methylated site (red) as well as four non-methylated sites (blue) of the mCpG DNA. 
Arrows indicate rapid exchange between these binding modes. (D) Overlay of 15N-HSQC spectra are 
shown for key reporter residues of MBD3 and MBD3KY while bound to DNA of varying lengths. 
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2.4.3 Residual dipolar couplings confirm MBD3 localizes to methylated sites without 
significant conformational change:  
As an alternative method to assess the ensemble of binding modes, we measured 
residual dipolar couplings (1DNH) for MBD3 bound to methylated and unmethylated 
DNA as well as for MBD3KY bound to methylated DNA. As can be seen in Figure 2.10, 
the observed 1DNH are similar but not identical between the different complexes. When 
plotting 1DNH from the unmethylated complex against those from wild type MBD3 or 
MBD3KY methylated complexes, the data fall off of the line of identity (y=x), as 
highlighted by the red ovals in Figure 2.10A-B. Since the observed residual dipolar 
couplings reflect a weighted average of the different binding modes, (29) the 1DNH for 
each residue (n) of MBD3 bound to mCpG is a linear combination of 1DNH for MBD3 
bound to CpG(x3) (non-specific binding mode) and 1DNH for MBD3KY bound to mCpG 
(methylation-specific binding mode): 
 
In Eq. (3), ρm is the fraction in the mCpG specific binding mode and 1DNH(n) are 
the residual dipolar couplings for each residue in the MBD3:mCpG, MBD3:CpG, and 
MBD3KY:mCpG complexes. Fitting the observed 1DNH to Eq. (3) as a function of ρm 
provides the fraction of MBD3 in the methylation-specific binding mode. As shown in 
Fig 2.10C, the sum of squared residuals (SSR) between predicted and observed 1DNH is 
minimized when ρm is 0.37. Plotting observed 1DNH,MBD3:mCpG versus predicted at ρm = 
0.37 shows good agreement with tight clustering around y=x (Fig. 2.10D). Therefore, 
using RDCs as an independent measure of methylation selectivity, we find that MBD3 
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the MBD3KY:mCpG and MBD3:mCpG complexes 
with the MBD3:hmCpG complex.  In contrast, the 
15N-HSQC spectra for the MBD3:hmCpG and 
MBD3:CpG(x3) complexes show nearly identical 
chemical shifts and spectra (Fig. 5A).  
These observations strongly support a binding 
model in which MBD3 exhibits fast exchange 
between methylation-specific and non-specific 
binding. Thus the observed chemical shift (σobs) 
reflects a weighted average of the methylation-
specific (σMBD3(KY):mCpG) and non-specific 
(σMBD3:CpG(x3)) binding modes, as given by: 
 
 σ obs = ρm iσ MBD3KY :mCPG + (1− ρm ) iσ MBD3:CPG(x3)   (2) 
where ρm is the fraction in the methylation-specific 
binding mode.  Hence, these chemical shifts are a 
direct measure of the average time spent on the 
mCpG site.   Using eleven backbone 1H,15N 
resonances that show a clear linear relationship 
between chemical shift and DNA bound, we find 
that MBD3 spends approximately 43% (±5%) of 
the time on the mCpG site (Fig. 3B).  
 These data further indicate that, despite a lack 
of a strong global binding affinity preference for 
mCpG DNA, MBD3 still spends a significant 
proportion of time on methylated sites. To confirm 
that this finding was not the result of very weak 
binding with chemical shift averaging between 
DNA bound and free MBD3, we compared 
HSQCs for 600µM and 300µM samples of protein 
on DNA.  The peaks for each reporter residue 
show nearly identical chemical shifts at both 
concentrations (Fig. 5B), indicating that the 
observed chemical shift changes of the reporter 
residues were not the result of exchange between 
bound and free states but instead represent 
averaging between different bound states.  The 
observed differences in chemical shift represent 
changes in the binding distribution on DNA, not 
changes in the distribution between bound and free 
states. 
We developed a statistical-mechanical model 
to describe the distribution of MBD3 on 
methylated DNA (Fig. 3C) in which the partition 
function comprises a sum of Boltzmann factors   
(e-E(i)/kT) for methylation-specific and non-specific 
binding modes, ΔE is the difference in energy 
between binding modes and N is the number of 
non-specific sites.  The additional methylation-
specific interactions formed by MBD2 lead to a 
larger ΔE thereby increasing ρm and the relative 
selectivity for mCpG.   Without these interactions, 
MBD3 shows a smaller ΔE, ρm is reduced but still 
non-zero, and MBD3 distributes unevenly between 
mCpGs and unmethylated sites. Figure 3C depicts 
a simplified structural model of this distribution in 
which the MBD3 structure was docked onto the 
17bp DNA fragment at the centrally methylated 
mCpG (red) as well as four “non-specific” binding 
sites (blue).   The statistical model further 
indicates that localizing to an mCpG depends on 
the number of non-specific sites available (N), and 
therefore the length of DNA. We tested this latter 
prediction by comparing chemical shifts for the 
reporter residues of MBD3 on 10, 17, and 27bp 
DNA with a single mCpG (Fig. 3D). Indeed, we 
found that increasing DNA length results in 
chemical shift changes for G27 and A30 toward 
the unmethylated binding mode. 
Residual dipolar couplings confirm MBD3 
localizes to methylated sites without significant 
conformational change: As an alternative method 
to assess the ensemble of binding modes, we 
measured residual dipolar c plings (1DNH) for 
MBD3 bound to methylated and unmethylated 
DNA as well as for MBD3KY ou d to methylated 
DNA.  As can be seen in Figure 4, the observed 
1DNH are similar but not identical between the 
different complexes.  When plotting 1DNH from the 
unmethylated complex against those from wild 
type MBD3 or MBD3KY methylated complexes, 
the data fall off of the line of identity (y=x), as 
highlighted by the red ovals in Figure 4A-B.   
Since the observed residual dipolar couplings 
reflect a weighted average of the different binding 
modes,(29) the 1DNH for each residue (n) of MBD3 
bound to mCpG is a linear combination of 1DNH for 
MBD3 bound to CpG(x3) (non-specific binding 
mode) and 1DNH for MBD3KY bound to mCpG 
(methylation-specific binding mode): 
 
 
 
1DNH ,MBD3:mCpGpred (n) =
ρm i
1DNH ,MBD3KY :mCpG
obs (n)+ (1− ρm ) i 1DNH ,MBD3:CpG(x3)obs (n)
!!(3) 
 
In Eq. (3), ρm is the fraction in the mCpG specific 
binding mode and 1DNH(n) are the residual dipolar 
couplings for each residue in the MBD3:mCpG, 
MBD3:CpG, and MBD3KY:mCpG complexes.  
Fitting the observed 1DNH to Eq. (3) as a function 
of ρm provides the fraction of MBD3 in the 
methylation-specific binding mode.   As shown in 
Fig 4C, the sum of squared residuals (SSR) 
between predicted and observed 1DNH is 
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spends approximately 37% of the time on the methylated binding site, which agrees 
within experimental error with the results from chemical shift analysis. 
The residual dipolar couplings for each complex were fit to the solution structure of 
MBD3 bound to hmCpG using singular value decomposition as implemented by the 
PALES software (30). Despite the differences in RDCs between complexes, each data set 
fit quite well to the MBD3 structure with Q factors of 19.9%, 23.1%, and 25.9% for the 
MBD3:mCpG, MBD3:CpG(x3), and MBD3KY:mCpG complexes, respectively (Fig. 
2.10E). Therefore, the change between methylated and non-specific binding modes does 
not involve backbone structural changes. The observed chemical shift changes likely 
reflect a stabilization of the dynamic loop between β2 and β3 but without significant 
structural rearrangements. 
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FIGURE 2.10: MBD3 localizes to 
methylated DNA sites without 
significant conformational change. A 
comparison of measured 1DNH RDCs 
normalized to 2H2O quadrupole splitting of 
10 Hz are plotted for (A) MBD3:mCpG vs 
MBD3:CpG(x3) and (B) MBD3:mCpG vs 
MBD3KY:mCpG complexes. Red ovals 
highlight those values that fall of the line 
of identity (gray line). (C) The sum of 
squared residuals (SSR) is plotted as a 
function of ρm (Eq. (3)). The SSR is 
minimized (red circle and arrow) at 37% 
mCpG bound (ρm = 0.37). (D) Plotting 
1DNH RDCs for MBD3:mCpG observed 
vs. predicted with ρm = 0.37 ((3)) shows 
good agreement with tight clustering 
around y = x. (E) The measured 1DNH 
RDCs for each complex (MBD3:CpG(x3), 
MBD3KY:mCpG, and MBD3:mCpG, left 
to right plots, respectively) were fit to the 
solution structure of MBD3 by SVD and 
the observed vs. predicted values plotted. 
The Q factors and correlation coefficients 
show good agreement with the solution 
structure indicating that the backbone 
structure of MBD3 does not change 
between complexes. 
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2.4.4 MBD2 and MBD3 distribution is influenced by DNA methylation status and CpG 
density:  
In contrast to MBD3, MBD2 appears to spend most of its time on the methylated 
site (Fig. 2.12A). The chemical shifts for reporter residues in MBD2 represent the 
extrema for the complexes studied. As shown in Figure 6B, these peaks do not change 
with increasing DNA length, indicating that a large ΔE dominates the fraction bound to 
the methylated site and ρm ≈ 1 (Fig. 2.9C). The higher affinity and methylation selectivity 
of MBD2 results in exclusive occupancy of mCpG. 
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FIGURE 2.11: Chemical shifts do not 
depend on concentration or the 
presence of hydroxymethlyation. 
Overlay of 15N-HSQC spectra are shown 
comparing a) MBD3:hmCpG (orange) 
with MBD3:CpG(3x) and b) 
MBD3:mCpG at 600 µM (blue) and 300 
µM (red). Resonances for key reporter 
residues A30 and G27 are labeled. 
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Comparing spectra of MBD2 and MBD3 when bound to the unmethylated 
oligonucleotides CpG(x0), CpG(x1) and CpG(x3) reveals that the reporter resonances 
shift towards the methylation-specific state with increasing numbers of CpGs (Fig. 2.9B 
and 2.13A). This finding indicates that both MBD2 and MBD3 localize to sites of 
increased CpG density. MBD3 shows relatively small chemical shift changes when 
bound to CpG(x3) as compared to CpG(x0), consistent with localizing to a CpG 
dinucleotide approximately 9% (±3%) of the time. MBD2 shows a pronounced difference 
between CpG(x0) and CpG(x3) (Fig. 2.12A) showing that MBD2 preferentially localizes 
to CpG dinucleotides approximately 33% (±11%) of the time. The reporter resonances 
also indicate that MBD2, but not MBD3, tends to localize to hmCpG and exhibits higher 
affinity for these sites (Fig. 2.12A, Table 2.3). To test whether MBD3 could influence 
how MBD2 distributes on unmethylated CpGs, we added equimolar MBD3 to 15N-
MBD2 bound to CpG(x3) and found that the reporter peaks shifted towards those of the 
non-specific binding mode (Fig 2.12A). This finding shows that despite relatively weak 
overall binding affinity, MBD3 can modulate the distribution of MBD2 on CpG sites, 
shifting MBD2 towards the non- specific binding mode. 
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FIGURE 2.12: MBD2 distribution 
is influenced by DNA methylation 
status and CpG density. (A) An 
overlay of 15N-HSQC spectra for 
key reporter residues of MBD2 
bound to CpG(0x), CpG(1x), 
CpG(3x) +/- MBD3, mCpG and 
hmCpG, shows that cMBD2 
preferentially localizes to DNA with 
mCpG, hmCpG and multiple CpG 
sites, and that localization is 
modified by the presence of 
equimolar MBD3. (B) An overlay of 
15N-HSQC spectra cMBD2 bound to 
mCpG DNA of varying lengths 
confirms that cMBD2 strongly 
prefers mCpG sites. 
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2.4.5 Global binding affinity does not reflect localization preferences on DNA:  
Binding affinities for each of the methylated and unmethylated sequences 
investigated were determined by steady-state analysis of surface plasmon resonance data, 
as described previously (18). To allow for direct comparison of binding stoichiometry, 
we normalized the relative steady-state response to the amount of DNA coupled to the 
sensor chip such that the maximum steady-state response reflects the number of binding 
sites on the DNA (25). As can be seen in Fig. 2.13 and Table 2.3, both cMBD2 and 
MBD3KY bind mCpG DNA with high affinity and stoichiometry of approximately one 
(KD = 105 ± 7 nM and113 ± 11nM and Rmax = 0.83 ± 0.01 and 0.98 ± 0.02, respectively). 
Both bind unmethylated DNA with much lower affinity and high stoichiometry (KD = 74 
± 4 µM and 17 ± 2 µM and Rmax = 4.8 ± 0.1 and 2.1 ± 0.1, respectively) indicative of a 
high degree of methylation selectivity.  
While NMR analyses indicate MBD3 binds DNA with sufficient affinity to be fully 
bound at 300µM concentration (Fig. 2.11B), solubility limits of the isolated protein 
preclude accurate determination of binding constants by surface plasmon resonance. The 
qualitative results of these studies, however, are very similar to those reported previously 
by Hashimoto et al. (15) who determined DNA binding affinity for full-length MBD3 by 
fluorescence anisotropy. In those previous studies, MBD3 bound with similar low affinity 
to unmethylated and hydroxymethylated DNA and with a small but weak preference 
(approximately five-fold) for methylated DNA. The current SPR data indicates a small 
preference for mCpG as well (Fig. 2.13). 
Likewise, cMBD2 shows similar low affinity and high stoichiometry when binding 
to hydroxymethylated and unmethylated DNA with 0-3 CpG dinucleotides (Fig. 2.13 and 
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Table 2.3). Therefore, global binding analysis reveals a marked preference for mCpG by 
cMBD2 and MBD3KY but only weak and non-specific binding for all other complexes. 
These findings agree with several previous DNA binding analyses of MBD proteins (4, 5, 
15, 18). 
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FIGURE 2.13: MBD2 and 
MBD3 localization does not 
translate into a global binding 
affinity preference. Steady state 
surface plasmon resonance 
measurements are shown for 
MBD3 (top panel) and cMBD2 
(bottom panel) binding to 
immobilized double stranded 
oligonucleotides of varying CpG 
content and methylation status. 
The steady-state response was 
normalized to the amount of DNA 
immobilized (Eq. (1)) such that 
the maximum response reflects 
the stoichiometry of binding (n). 
 
 
Table 2.3: Binding affinity. The 
dissociation constant (KD), Rmax, 
and Chi2 are given for different 
protein and DNA complexes as 
determined by steady state 
analysis of surface plasmon 
resonance studies. 
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Table 3.  Binding affinity. The dissociation constant (KD), Rmax, and Chi2 are given for different 
protein and DNA complexes as determined by steady state analysis of surface plasmon 
resonance studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein DNA KD (µM) ± SE Rmax* Chi2 (x10-3) 
MBD3 mCpG 54 ± 7 3.2 25 
MBD3 CpG(x3)   n.d.** - - 
MBD3 CpG(x1) n.d. - - 
MBD3 CpG(x0) n.d. - - 
MBD3 hmCpG n.d. - - 
MBD3KY mCpG) 0.13 ± 0.01 1.0 2.6 
MBD3KY CpG(x3) 17 ± 2 2.1 1.8  
MBD2 mCpG 0.11 ± 0.01 0.8 1.0 
MBD2 CpG(x3) 74 ± 4 4.8 3.8  
MBD2 CpG(x1) 78 ± 7 4.8 7.2 
MBD2 CpG(x0) 68 ± 3 5.4 5.9 
MBD2 hmCpG 54 ± 8 4.3 51 
*Normalized such that Rmax reflects stoichiometry (n) 
**Weak binding and solubility limits preclude accurate determination of 
binding affinity.  by guest on December 5, 2013
http://www.jbc.org/
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2.5 DISCUSSION 
 
Although it has been established that MBD3 binds DNA with lower affinity and 
much less specificity for mCpG dinucleotides than MBD2, the functional role of MBD3 
has not been well defined. Based on NMR structural, chemical shift, and residual dipolar 
coupling analyses, we have demonstrated that MBD3 binding to methylated DNA can be 
described by an ensemble of methylation-specific and non-specific binding modes and 
that MBD3 preferentially localizes, albeit weakly, to methylated sites. In contrast to 
MBD2, MBD3 does not distinguish between hydroxymetylated and unmethylated DNA 
but does show a slight preference for DNA with multiple CpG dinucleotides.  
A similar chemical shift analysis of cMBD2 showed that cMBD2 localizes almost 
exclusively to the methylated sites when present. Even on unmethylated DNA, cMBD2 
preferentially localizes to CpG dinucleotides, especially as the number of available CpGs 
increases. Surprisingly, cMBD2 more avidly localized to a hydroxymethylated than an 
unmethylated site. Taken together, these findings lead to a model in which both MBD2 
and MBD3 preferentially localize to DNA with multiple CpGs while MBD2 more 
exclusively localizes to mCpGs. 
Our studies lead to several novel observations and hypotheses. First, the differences 
in DNA binding between MBD3 and MBD2 reflect a change in the degree of selectivity 
for mCpG, not absolute differences in binding specificity. As we hypothesized, both 
MBD2 and MBD3 show a weak preference for CpG dinucleotides even the absence of 
methylation; however, MBD2 shows a much greater selectivity for mCpG than MBD3. 
These preferences are not necessarily apparent by global binding analyses but instead are 
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reflected in the partitioning between methylation-specific and non-specific binding 
modes on DNA, observed via NMR analysis.  
The observed changes in the NMR spectra arise from changes in the distribution of 
bound states, not from changes in the distribution between bound and free states. In 
addition, the preference, though weak, for multiple CpG sites within the relatively small 
17-base pair oligonucleotide used in these studies correlates with the whole genome 
analyses that show MBD2 and MBD3 localize to CGIs. Given that a CGI contains 100-
1000s of CpG dinucleotides, even a relatively small preference would lead to fairly 
strong localization at such sites. Furthermore, these findings correlate with the 
observations that both MBD2 and MBD3 are found at unmethylated CGIs, whereas 
MBD2 binds with much greater affinity and likely excludes MBD3 from methylated 
CGIs. Finally, these studies clearly indicate that MBD3 does not exhibit a binding 
preference for or a structural recognition of hmCpG DNA. From the standpoint of 
MBD3, hydroxymethylation is functionally equivalent to demethylation. 
Genomes containing both MBD2 and MBD3 proteins emerge at the same time as 
the vertebrate methylation pattern, which includes largely unmethylated CGIs. This 
concurrence along with the preceding characterization of DNA binding by MBD3 leads 
us to speculate that MBD3 plays an important role in regulating genes with unmethylated 
CGIs. One possibility these studies raise is that MBD3 helps counterbalance the tendency 
of MBD2 to preferentially localize to CpG dinucleotides, and consequently to aberrantly 
silence the associated genes, by competing with MBD2 at unmethylated CGIs.  
We found that MBD3 does modify the distribution of MBD2 on DNA such that 
MBD2 spends less time on CpG sites. Thus MBD3 could help prevent gene silencing by 
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MBD2 at unmethylated gene promoters and enhancers depending on the relative 
concentration of the two proteins and cellular context. Indeed, recent studies have shown 
that knockdown of MBD3 can lead to decreased gene expression (16, 17). 
Mammalian cells express multiple MBD proteins as well as different isoforms of 
individual MBDs. Different splice variants as well as distinct genes encode for MBD2 
and MBD3 proteins, some of which lack the DNA binding domain itself. Here, we have 
studied the solution structure and DNA binding of MBD3 by NMR. Chemical shift 
analyses indicate that MBD3 recognizes and preferentially localizes to both mCpG and 
CpG sites but not to the same extent as MBD2. Single amino acid differences dictate the 
degree to which these proteins localize on mCpG sites. Importantly, these binding 
characteristics do not necessarily lead to changes in global binding affinities but rather 
correlate with localization of MBD2 and MBD3 to CGIs in whole cells. Hence, a number 
of different NuRD complexes can be formed that show varying degrees of DNA 
methylation selectivity and provide distinct functional roles. For MBD3, these functional 
differences appear to reflect subtle distinctions in the behavior of the MBD when bound 
to methylated and unmethylated DNA. Indeed, recent studies have shown that MBD3-
NuRD may serve multiple roles in modifying expression for both active and silent genes 
through localization at promoters, gene bodies, and enhancers of active genes (31). 
Therefore, these data establish a structural basis for the relative distribution of MBD2 and 
MBD3 on genomic DNA and help explain their observed occupancy at CpG-rich 
promoters. 
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Chapter 3- Sponge MBD2 targets methylated DNA and 
recruits NuRD components 
 
3.1 ABSTRACT 
 
Invertebrates and vertebrates exhibit substantial variation in DNA methylation 
patterns. Methyl-cytosine binding domain (MBD) family members also vary in both 
types of organisms. Whereas invertebrates are known to express only MBD2/3 homologs, 
vertebrates harbor several MBD family members. Expansion of the MBD family appears 
to have accompanied the invertebrate-vertebrate transition, though MBD2 preference for 
methylated DNA has largely been retained throughout the animal lineage. Sponges 
represent the base of the animal kingdom, and recent genomic analyses of sponges 
Amphimedon queenslandica and Ephydatia muelleri indicate the presence of individual 
genes for MBD2/NuRD complex members; no other MBD family members have been 
identified in sponge genomes. We questioned whether or not sponge MBD2 targets the 
NuRD complex to methylated DNA, like other metazoan orthologs, and assessed the 
ability of MBD2 to select for methylated DNA and recruit NuRD components in the 
freshwater sponge Ephydatia muelleri. We observed that Ephydatia MBD2 binds 
methylated DNA with approximately 150-fold selectivity over unmethylated, compared 
to a 430-fold preference for methylated DNA exhibited by human MBD2. The Ephydatia 
MBD2 and p66α coiled-coil regions display low identity with human and little pre-
formed helical content, but nevertheless, the sponge proteins possess nearly all amino 
acid residues necessary for high affinity binding observed by the human MBD2-p66α 
coiled-coils. Despite this similarity, the sponge coiled-coils bind weakly, though 
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interactions between the sponge and human coiled-coils occur much more avidly. 
Further, the Ephydatia MBD2 p55BR recruits human MTA2, but not human NuRD 
components HDAC 1/2 and Rbap 46/48, unlike the human p55BR, which can recruit all 
three NuRD core components. Finally, RNAi-induced knockdown of Ephydatia MBD2 
results in a low-growth phenotype marked by failure to form structures associated with 
early development in sponges. Taken together, these data suggest that sponges likely 
likely harbor a methylation-specific NuRD complex similar to that found in humans and 
thus have the capacity to carry out sophisticated epigenetic processes, including targeted 
chromatin remodeling, that likely pre-date sponge emergence.  
 
3.2 INTRODUCTION 
 
 Patterns of DNA methylation changed during the transition from invertebrate to 
vertebrate life. While invertebrate methylomes often harbor “mosaic” methylation 
patterns in gene bodies, vertebrates tend to show a global methylation pattern that often is 
observed in promoter regions and gene bodies (1) and appears to correlate with an 
expansion of the DNA methyltransferase and methyl-cytosine binding domain (MBD) 
families (2).  
 DNA methylation represents an abundant epigenetic mark in vertebrates, while 
many invertebrates lack detectable cytosine methylation (1). Notably, this is the case for 
several invertebrate organisms, including several invertebrate model organisms (e.g., 
yeast, fruit fly, and worm) (3). Most tested invertebrates, though, show mosaic 
methylation. But, the sea squirt Ciona intestinalis represents the only invertebrate for 
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which a detailed map of this pattern has been determined (4). Nevertheless, research 
continues to demonstrate the pervasiveness of cytosine methylation as an evolutionarily 
ancient genomic regulatory mechanism. Further, given that DNA methylation is a 
mechanism for regulating endogenous gene expression and possibly reducing 
transcriptional noise, research suggests that a reduction in unnecessary gene expression 
may have permitted the increase in gene number and in complexity that characterizes 
animals (5). 
Sponges represent the most ancient and primitive animal (6) and share with fungi a 
common evolutionary history in that their last common ancestor was likely a flagellated 
protist similar to the choanoflagellate (7). Despite their distinct morphological separation 
from other animals, studies of sponges have shed light on the molecular evolution of 
animals. Like higher animals, the sponge genome harbors genes crucial for growth and 
differentiation, cell-cycle regulation, cell-cell adhesion, and self versus non-self 
recognition (8).  Sponges also share in common with animals numerous transcription 
factor, sensory transduction, and cell adhesion genes (9).  
However, little study of Poriferan epigenetic regulation has been carried out. 
Although the recently sequenced Amphimedon queenslandica genome highlights 
numerous molecular framework similarities between sponges and other animals, much is 
still unknown regarding the epigenetic machinery in place at the dawn of metazoans. 
Given the phylogenetic position of sponges at the base of the animal kingdom, 
elucidating their epigenetic machinery will better clarify epigenetic regulation carried out 
by the last common ancestor to all animals. This information will tell us more about the 
origins of the epigenetic machinery present in vertebrates. Characterizing these features 
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throughout animal developmental history could be highly useful regarding study of 
human epigenetics. 
Vertebrates harbor a divergent family of methyl-cytosine binding domain (MBD) 
proteins critical for reading DNA methylation as an epigenetic mark. MBD family 
members include MeCP2 and MBD1-4. MBD1, MBD2, MBD3 are one sub-family: 
MBD1 and MBD2 prefer methylated DNA while MBD3 does not, at least not to the same 
extent. MBD4 and MeCP2 represent a second, more recent sub-family containing an 
insertion that leads to a longer alpha helix and larger hydrophobic core. MeCP2 is 
important for neurologic development while MBD4, through its associated glycosylase 
domain, repairs TpG/CpG mismatches (4). 
MBD2 can be found throughout the animal kingdom and its structural components 
primarily consist of a methyl-cytosine binding domain followed by a region implicated in 
binding the RbAp46/48 homolog p55 (p55-binding region; p55BR) (10) and a C-terminal 
coiled-coil (CC) region. MBD2 targets methylated DNA with high affinity through 
highly conserved DNA contacting amino acid residues located within its methyl-cytosine 
binding domain.  
MBD2 associates the ATP-dependent nucleosome remodeling and deacetylase 
complex (NuRD) (11). Six core proteins comprise the complex and constitute its ability 
regulate gene expression at the chromatin level: MBD2 or MBD3; histone deactylase 
(HDAC) 1 or HDAC2; chromatin remodeling enzyme Mi-2α (CHD3) or Mi-2β (CHD4); 
p66α (GATAD2A) or p66β (GATAD2B); metastasis-associated (MTA) protein (i.e., 
MTA1, MTA2, or MTA3); retinoblastoma-binding protein (RBBP; also known as 
RBAP48) 4 or RBBP7 (RBAP46). The MBD protein targets the complex to DNA while 
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HDAC1 or HDAC2 enzymatically removes acetyl groups from histone tails. The Mi-2 
subunit carries out chromatin remodeling in part by repositioning nucleosomes. The 
p66α, p66β, RBBP4, and RBBP7 subunits are likely structural subunits of the complex 
that interact with histone tails. The p66α/β proteins contain two highly conserved regions: 
an N-terminal coiled-coil domain (CR1) and a C-terminal GATA-like zinc finger domain 
(CR2) (12, 13). The MTA protein is thought to localize the complex to different cell-
specific targets by associating with transcription factors (14). 
The coiled-coil region of human MBD2 binds the p66α coiled-coil domain 
(conserved region 1- CR1) forming a high affinity heterodimeric complex that recruits 
Mi-2α/β and correlates with in vivo methylation dependent transcriptional repression 
(15). This unique coiled-coil interaction results in a heterodimeric complex that forms 
from anti-parallel association between two peptides that are largely monomeric in 
isolation. Helical content and specific electrostatic interactions between charged residues 
on the individual coiled coil domains drive the high affinity binding observed (16). This 
suggests that isoforms of MBD2 and p66α exhibiting a reduction in helical content will 
bind p66α with reduced affinity.  
The MBD2 p55BR lies between the methyl-cytosine binding domain (MBD) and 
the coiled-coil domains of MBD2. The first two-thirds of the region recruits the NuRD 
core components RbAp46/48, HDAC1/2 and MTA1/2. Furthermore, two conserved 
residues Arg286 and Leu287, establish critical contact points for complex formation 
(Desai, MA, unpublished data). This region has been determined to display an 
evolutionarily conserved, positive isoelectric point along with a largely unstructured 
architecture in isolation. Despite its unstructured architecture, the p55BR enhances the 
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affinity of MBD2 to methylated DNA by approximately 100-fold. (Desai, MA, 
unpublished data).  
NuRD complex components have previously been identified in organisms 
throughout the metazoan line including plants and worms, and more recently, in the 
sponges Amphimedon queenslandica (9) and Ephydatia muelleri (unpublished data, 
Pohlman D.). Whether or not the gene products identified in these two sponge species 
form an intact and/or functional NuRD complex remains unclear. Given the 
characteristics of the human MBD2, and if methylation patterns are intrinsically different 
between vertebrates and invertebrates, we initially asked the following questions: (1) 
Does the MBD2 complex still target methylated DNA? (2) Does MBD2 recruit NuRD 
components in the same manner? (3) What are the functional consequences of MBD2 
knockdown?  
To answer these questions, we cloned, expressed, purified, and determined the 
methylation selectivity of Ephydatia MBD2 MBD by surface plasmon resonance (SPR). 
We also cloned, expressed, and purified the coiled-coil domains from Ephydatia MBD2 
and p66α and assessed complex formation using analytical ultracentrifugation (AUC) and 
isothermal titration calorimetry (ITC). We assessed the temperature-dependent helical 
properties of Ephydatia MBD2 and p66α in isolation and in complex using circular 
dichroism (CD). We further cloned, expressed, and purified the full-length Ephydatia 
p55BR along with a shorter version of the protein consisting of the first two-thirds of the 
protein. RNAi-mediated knockdown of Ephydatia MBD2 and observation of subsequent 
phenotypic effects was carried out by a collaborator.  
Here, we show that Ephydatia MBD2 clearly prefers methylated DNA with a 
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binding affinity close to that of human and chicken. However, the binding constant of the 
sponge MBD2-p66α complex is approximately 1000-fold weaker than the human 
complex. ITC of E.m.-H.s. complexes (either E.m. p66α:H.s. MBD2 or E.m. MBD2:H.s. 
p66α) indicate higher affinity binding. We performed cross-species pull-down assays 
involving the Ephydatia MBD2 p55BR and found that the protein recruits human MTA2 
but not human HDAC1/2 or RbAp 46/48. RNAi-mediated knockdown of Ephydatia 
MBD2 results in a low-growth phenotype marked by failure to form structures associated 
with early development in sponges. These data suggest that sponges likely have the 
capacity to carry out sophisticated epigenetic processes, including targeted chromatin 
remodeling, that likely predate sponge emergence.  
 
3.3 EXPERIMENTAL PROCEDURES 
 
3.3.1 Purification of proteins and DNA:  
The coiled-coil regions of human MBD2b (amino acids 211-244), 
p66α  (amino   acids 137-178) and Ephydatia muelleri MBD2 (amino acids 182-212) and 
p66α (amino acids 58-101) were cloned and expressed with a hexahistidine tag and as 
thioredoxin fusion proteins in a modified pET32a vector. The expression vectors were 
transformed into the Rosetta BL21 (DE3- Invitrogen) E. coli strain, grown in Luria 
Bertani medium at 37°C 
 
and induced with 1 mM isopropyl-β-d-thiogalactopyranoside at 
an A600 ~ 0.8. The bacteria were harvested after 2 hours of induction and lysed 
ultrasonically in the presence of B-PER reagent (Thermo Scientific). The soluble fraction 
was passed over a nickel-sepharose column with the tagged protein eluted by a step 
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gradient of imidazole and further purified by gel filtration over a Superdex-75 column 
(GE Healthcare). The thioredoxin fusion proteins were used directly for analytical 
ultracentrifugation (AUC) and isothermal titration calorimetry (ITC) studies. For circular 
dichroism (CD) studies, clones were modified to incorporate a tyrosine residue just after 
the thrombin cleavage site (for quantification of the isolated peptide by UV 
measurement) and were expressed in a similar manner. After purification over a nickel-
sepharose column, the thioredoxin tag was separated from the rest of the peptide by 
thrombin digest and isolated by gel filtration chromatography over a Superdex-75 column 
(GE Healthcare). Specific mutations were introduced using the QuikChange Lightning® 
site-directed mutagenesis kit (Stratagene) following the manufacturers protocol. The final 
concentrations of all protein samples were determined by UV absorbance at 280 nm. The 
17-bp complementary oligonucleotides (Table 2 of the previous chapter) were purchased 
(Integrated DNA Technologies), annealed and purified as previously described. The 
sequences were derived from the p16INK4a promoter known to be a native target sequence 
for MBD2, as mentioned in the previous chapter. 
Two E.m. MBD2 p55BR constructs were cloned into the pCMVTag2B (Stratagene) 
vector in frame with an N-terminal Flag-tag sequence: full-length p55BR (amino acids 
90-181) and short (amino acids 90-181). These constructs were used in the co-
immunoprecipitation procedure discussed below.    
 
3.3.2 Binding affinity:  
Binding affinities were determined by surface plasmon resonance analysis on a 
Biacore T100 system (GE Healthcare) as described previously. The binding affinity was 
determined from steady state analysis of the SPR relative response at varying 
	   77	  
concentrations of protein. As previously shown, the maximum steady state response 
(Rmax) in SPR depends on stoichiometry (n) of binding. Prior to fitting, the steady state 
response at each protein concentration (RA) was normalized (Rnorm) to the total DNA 
immobilized (Rl) and molecular weights of the DNA and protein (MWL and MWA, 
respectively). 
 
Final data analysis, plotting, and curve fitting were performed with pro Fit software 
(QuantumSoft). 
 
3.3.3 Analytical ultracentrifugation: 
Sedimentation velocity experiments were carried out using Beckman Optima XL-I 
analytical ultracentrifuge (Beckman Coulter Inc.) equipped with a four and eight-position 
AN-60Ti rotor. Sedimentation was performed at 40,000 rpm, 20°C, under physiological 
buffer conditions (20 mM Tris pH 8.0, 150 mM NaCl). Sedimentation profiles were 
recorded using UV absorption (280 nm) and interference scanning optics. The partial 
specific volume (V) of the sample, 
density   (ρ)   and   viscosity   (η)   of   the   buffer   were   calculated   using      the   SED
NTERP   program (25). Data was fit using a continuous size distribution (c(s)) and the 
effective molecular weight determined from the resulting sedimentation coefficients with 
the SEDFIT software (26). 
 
 
 
 
The dynamic distribution of MBD3 on DNA 
! 3!
dipolar couplings were measured for complexes 
containing 2H,13C,15N labeled protein using 
standard IPAP experiments and samples aligned 
by adding ~12mg/mL pf1 bacteriophage (Asla 
Biotech, Ltd.).  For each aligned sample, a 1D 2H 
spectrum of 2H2O was collected and the deuterium 
quadrupole splitting measured.  When comparing 
RDC values between samples, the observed RDC 
values were normalized to an effective deuterium 
quadrupole splitting of 10 Hz. 
Structure Calculations: The structure of the 
MBD3 MBD was calculated by simulated 
annealing as implemented in the Xplor-NIH 
software package (21) and based on NOE derived 
distance constraints, torsion angle restraints, and 
residual dipolar couplings as well as a torsion 
angle database potential of mean force (22) and a 
quartic van der Waals repulsion term for non-
bonded contacts.(23)   Backbone torsional angle 
restraints were derived from chemical shifts using 
the TALOS+ software (24) and hydrogen bond 
distance and angle restraints were introduced 
based on backbone torsional angles and 
characteristic NOE patterns. 
Binding affinity: Binding affinities were 
determined by surface plasmon resonance analysis 
on a Biacore T100 system (GE Healthcare) as 
described previously.(18)  The binding affinity 
was determined from steady state analysis of the 
SPR relative response at varying concentrations of 
protein.  As previously shown, the maximum 
steady state response (Rmax) i  SPR depends on 
stoichiometry (n) of binding.(25)    Prior to fitting, 
the steady state res onse at each protein 
concentration (RA) was normalized (Rnorm) to the 
total DNA immobilized (Rl) and molecular 
weights of the DNA and protein (MWL and MWA, 
respectively). 
 
 
Rnorm =
RA
RL i
MWA
MWL
⎛
⎝⎜
⎞
⎠⎟
  (1) 
Final data analysis, plotting, and curve fitting were 
performed with pro Fit software (QuantumSoft).   
 
RESULTS 
Solution structure of the MBD3 MBD is nearly 
identical to that of MBD2: We determined the 
solution structure of the MBD from MBD3 (amino 
acids 1-70) bound to a 17bp dsDNA with a central 
hydroxymethylated CpG dinucleotide. The 
structure was calculated based on 528 NOE 
derived distance constraints, 120 dihedral angle 
restraints, and 53 residual dipolar coupling 
restraints (Table 2).   The overall protein structure 
is well defined (Fig. 1A-B) with average pairwise 
root mean square deviations (RMSD) of 0.7±0.1 Å 
(backbone) and 1.2±0.1 Å (all heavy atoms) for 
ordered regions (residues 6-23,34-71).   As 
expected, the fold is very similar to that of chicken 
MBD2 (cMBD2; RMSD=2.0±0.1 Å) for the same 
ordered regions (Fig. 1D).(18)   
As with all MBD proteins studied to date, the 
topology of the MBD comprises a four-stranded β-
sheet followed by a single α-helix and a C-
terminal loop.  The central two strands of the β-
sheet (β2 and β3) form a long finger-like 
projection that can extend down and across the 
major groove of DNA to make base specific 
contacts.  The most notable difference between the 
cMBD2 and MBD3 structures is that the loop 
connecting the long fingerlike projection is not as 
well ordered in MBD3 (residues 24-33, Fig. 1A,C) 
with an RMSD of 1.7±0.5 Å (backbone) as 
compared to cMBD2 with an RMSD of 0.9±0.3 Å.  
Residues at the base of this loop form critical 
DNA specific contacts and a hydrogen bond 
network that stabilizes the interaction with the 
methylated CpG dinucleotide (Fig. 1E).  
Predicting backbone order parameters (S2) 
based on chemical shifts using the random coil 
index (RCI) method (24, 26) confirms that this 
loop is less well ord red in MBD3  (Fig. 2).  The 
difference in predicted S2 between complexes and 
shows that residues 24-33 become progressively 
more ordered between the MBD3:hmCpG, 
MBD3:mCpG and cMBD2:mCpG complexes, 
respectively.   Thus in the absence of a 
methylation-specific binding mode, the loop 
connecting the central two β-strands is more 
flexible. 
Filtered intermolecular NOE spectra did not 
contain NOE crosspeaks, which is consistent with 
the observed line broadening for residues at the 
DNA interface and the overall lower affinity of 
MBD3 for DNA and suggests non-specific 
protein-DNA interaction with dynamic exchange 
between binding sites.   Based on subsequent 
analyses that indicate MBD3 preferentially 
localizes to methylated sites, we collected filtered 
NOE spectra for MBD3 bound to methylated 
DNA (mCpG). Likewise, we did not detect any 
intermolecular NOE crosspeaks with methylated 
 by guest on December 5, 2013
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3.3.4 Isothermal titration calorimetry: 
Protein samples were buffer exchanged into (50 mM Hepes pH 7.4, 150 mM NaCl) 
and binding analyzed with an iTC200 Microcalorimeter (GE Healthcare). A total of 24 
injections (1.5 µL each)  of  the  p66α  coiled-coil (100 µM) were injected into MBD2 
and homologues (10 µM, 298 K, stir speed of 400 rpm, 120 seconds time delay between 
injections). The resulting isotherms were auto adjusted for baseline and fit to a one-site 
binding model using Origin 7.0 software to determine binding constant 
(KD)   and   enthalpy   (ΔH)   while   the   Gibbs   free   energy  (ΔG)  and  entropy  (ΔS)  
of  binding  were  calculated  according  to  Equation  1.1,  
−RTln(K)  =  ΔG  =  ΔH  – TΔS (Equation 1.1),  
where T is the temperature in Kelvin and R is the gas constant. 
 
3.3.5 Circular dichroism: 
CD spectra were collected on purified peptide samples (~33 mg/mL total protein in 
10mM sodium phosphate, pH 6.5) with a JASCO J-715 CD spectrometer (JASCO Corp) 
at 293 K, with a 1-cm path length, scanning from 190-260 nm with 0.5 nm interval at a 
scanning speed of 50 nm/min. CD spectra were normalized to give molar ellipticity 
values(θ) in degrees·cm2·dmol-1residue.
 
Helical  content  for  each  peptide  was  calculated  from  the  ratio  of  the  observed 
θ222nm
  
to the expected θ222nm for 100% helix as given by 40,000 × [(n − 4)/n], where 
n is the number of residues.  Thermal denaturation was  followed  at  θ222nm from 277-
368K at 1 K intervals with a heating rate of 1 K/min. The data were fit to a simple two 
state thermodynamic model of unfolding. 
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Helical content prediction 
The expected helical content for each peptide was calculated using the AGADIR 
(27) algorithm with the N- and C-termini  ‘free’, at 293 K, ionic strength of 0.02, and pH 
6.5 to closely match the experimental conditions for CD. The predicted helical content 
was used to help design amino acid changes that stabilize helix formation. 
 
3.3.6 Co-immunoprecipitation studies: 
 Various MBD2 constructs were cloned into the pCMVTag2B (Stratagene) vector 
in frame with an N-terminal Flag-tag sequence. HEK 293T cells were transfected with 
the constructs (18 ug plasmid DNA) by calcium phosphate precipitation method 17 and 
harvested after 48 hours. Cells were lysed and immunoprecipitated with anti-Flag M2 
antibody (Sigma) and mouse IgG (Santa Cruz) controls according to the Sigma Flag-IPT 
kit protocol (Sigma-Aldrich, Inc., St. Louis, MO). The precipitated proteins were then 
analyzed for different components of the MBD2/ NuRD complex by western blot using 
antibodies against RbAp48 (Abcam), HDAC2 (Millipore) and MTA2 (Santa Cruz). 
 
3.3.7 RNAi studies:  
The following MBD2 RNAi procedure carried out in Ephydatia muelleri  was 
provided by April Hill, Ph.D., Department of Biology, University of Richmond, 
Richmond, Virginia. 
 Ephydatia muelleri gemmules were grown following the protocol in Rivera et al. 
2011, with 2-3 gemmules sharing a single well. After the gemmules attached, 10,000 ng 
of dsRNA was mixed with 1 mL of Strekal’s media in 3 of the six wells in which the 
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sponges grew (Strekal and McDiffett 1974). After 24h, media was changed, and the same 
3 wells received another 10,000ng of dsRNA. 48h after the original treatment, gemmules 
were scored for growth, size, number of oscula, and canal structure. They were 
photographed on a stereomicroscope. 
dsRNA Synthesis: 
The methyl binding domain of MBD2/3 was amplified from Ephydatia cDNA using 
these primers: F: 5’ – CGACTCACTATAGGGTTGCGGGTGAAGGGCTTG – 3’, R: 5’ 
– CGACTCACTATAGGGGCCATCGCCAGGGGAAC – 3’. The primers contain 
partial T7 sites that flank the ~204bp amplicon. The full T7 site was added in a 
subsequent PCR, using a complementary primer that matched the partial T7 site. Both 
reactions were run in the thermocycler at: 94°C for 3 min, 30 cycles of 94°C for 30s, 
57°C for 30s, 72°C for 1 min, followed by a 5 minute final extension at 72°C. PCR 
products were again run on a gel and the correct bands excised and purified. This product 
was used to make double-stranded RNA (dsRNA) using the T7 RiboMAXTM Express 
RNAi System (Promega). dsRNA was quantified using a NanoDrop. 
 
3.4 RESULTS 
 
3.4.1 Ephydatia muelleri MBD2 targets methylated DNA.  
 Alignment analysis indicates the Ephydatia and human MBD2 methyl-cytosine 
binding domains share high identity (73%) as seen in figure 3.2, but less similarity 
throughout the remainder of MBD2 (see the clustal analysis- figure 3.3). As can be 
observed in figures 3.2 and 3.3, the sponge sequence contains all amino acids known to 
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Figure 3.1: Domain organization of the 
Homo sapiens MBD2 and p66α. GR, glycine-
arginine repeat region; MBD, methyl-binding 
domain; CR1 is a coiled-coil domain; CR2 
includes a GATA zinc finger domain. 
contact DNA and found in the loop connecting the central two beta strands of the beta 
sheet: R24, G27, A30, H32, D34, F36, R46. This, along with the overall high identity 
between Ephydatia and human MBD2 MBD, prompted us to surmise that the sponge 
MBD would target methylated-CpG sites with similarly high affinity. To assess the 
binding affinity of the Ephydatia MBD2 MBD for methylated and unmethylated 
sequences DNA steady-state analysis of surface plasmon resonance data was conducted, 
as described in the previous chapter. To 
allow for direct comparison of binding 
stoichiometry, we normalized the relative 
steady-state response to the amount of DNA 
coupled to the sensor chip such that the 
maximum steady-state response reflects the 
number of binding sites on the DNA. As can 
be seen in Fig. 3.4 and Table 3.1, both the 
human and Ephydatia MBD2 MBD bind 
mCpG DNA with high affinity and 
stoichiometry of approximately one (KD = 0.19 ± 0.03 µM and 0.43 ± 0.09 µM, 
respectively and Rmax = 1.2, for both human and Ephydatia). Both bind unmethylated 
DNA with much lower affinity and high stoichiometry (KD = 82 ± 5 µM and 65 ± 2 µM 
and Rmax = 7.3 and 7.9, respectively) indicative of a high degree of methylation 
selectivity. However, human MBD2 selects methylated DNA with a 430-fold higher 
affinity over unmethylated, whereas, Ephydatia MBD2 binds with a 150-fold higher 
affinity than unmethylated DNA. 
!!!!!!! ! !!!!!!!!! !!!!!!!!!! !!!
GR-rich 
region 
MBD2a 
MBD p55 binding region 
(p55BR)  
Coiled-coil 
region 
MBD2b 
MBD p55 binding region 
(p55BR)  
Coiled-coil 
region 
p66α 
CR1 CR2 
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Figure 3.2: Alignment of the Homo sapiens and Ephydatia muelleri MBD2 methyl-cytosine 
binding domains.  
Figure 3.3: Clustal alignment of the Homo sapiens MBD2 versus Ephydatia muelleri MBD2a 
and MBD2b.  
ALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLARYLGNTVDLSSFDF  58  Human MBD2 MBD                      
 LP GWK+E V+RK+G SAGK+DVYYFSP GKKFRSKPQ+AR+LG+ VDL+ FDF    
GLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIARFLGDAVDLTCFDF  59  Ephydatia MBD2 MBD 
 !
CLUSTAL 2.1 multiple sequence alignment
EmMBD2a         MSSSSPPEYETVRTELRVKGLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIA 60
EmMBD2b         MSSSSPPEYETVRTELRVKGLPSGWKREVVVRKNGQSAGKTDVYYFSPCGKKFRSKPQIA 60
HsMBD2b         ---------------MDCPALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLA 45
                               :   .**.***:* *:**.* ****:*******.*********:*
EmMBD2a         RFLGDAVDLTCFDFSRAGSPGDGTQRRRARDRNLGSPGGGGGGGGGAGGHHSHSNGGTSS 120
EmMBD2b         RFLGDAVDLTCFDFSRAGSPGDGTQRRRARDRN--------------------------- 93
HsMBD2b         RYLGNTVDLSSFDFRTGKMMPSKLQKNKQRLRN--------------------------- 78
                *:**::***:.***  .    .  *:.: * **                           
EmMBD2a         AGNIVTRRSDHKPSSGSKPLSTNPLRP----SGPVRRTCGVIKLPVIWVAPPNNEQVRDE 176
EmMBD2b         -----------------KPLSTNPLRP----SGPVRRTCGVIKLPVIWVAPPNNEQVRDE 132
HsMBD2b         -----------------DPLNQNKGKPDLNTTLPIRQTASIFKQPVTKVTNHPSNKVKSD 121
                                 .**. *  :*    : *:*:*..::* **  *:   .::*:.:
EmMBD2a         CVILDQKRDVAVHVVVQTHWERRLGGFKPCDHATGSDIAFHRVPNGTVDGSATKKPAASQ 236
EmMBD2b         CVILDQKRDVAVHVVVQTHWERRLGGFKPCDHATGSDIAFHRVPNGT------------- 179
HsMBD2b         PQRMNEQP-------RQLFWEKRLQGLS-ASDVTEQIIKTMELPKGLQG----------- 162
                   ::::         * .**:** *:. ....* . *   .:*:*              
EmMBD2a         QTPAASASSKTQSSVLSHLPTPFLTSASPVSSLASQSPRSTNAPAGPPVHSGTDTLSANG 296
EmMBD2b         ------------------------------------------------------------
HsMBD2b         -----VGPGSNDETLLSAVASALHTSSAPITG---------------------------- 189
                                                                            
EmMBD2a         PSASQQQTHSSTHSLVSNGSSAQTVELSLPLVTESVVRAQEERVRLIRQQLLAAQSISS- 355
EmMBD2b         --------------------------LSLPLVTESVVRAQEERVRLIRQQLLAAQSISS- 212
HsMBD2b         ------QVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADIL 243
                                           .  :**:. :* *****: :*::*  *   .  
EmMBD2a         -------------------
EmMBD2b         -------------------
HsMBD2b         SRAADTEEMDIEMDSGDEA 262
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     HsMBD2 mCpG 0.19 ± 0.03 1.2 87 
HsMBD2 CpG(x3) 82 ± 5 7.3 17 
cMBD2 mCpG 0.20 ± 0.01 1.0 0.90 
cMBD2 CpG(x3) 74 ± 4 4.8 3.8 
EmMBD2 mCpG 0.43 ± 0.09 1.2 0.10 
EmMBD2 CpG (x3) 65 ± 2 7.9 8.1 
 
*Normalized such that Rmax reflects stoichiometry (n) 
 !
Figure 3.4: Ephydatia MBD2 selectively targets methylated DNA. Steady state surface plasmon 
resonance measurements are shown for MBD2 binding to immobilized double stranded methylated or 
unmethylated oligonucleotides. The steady-state response was normalized to the amount of DNA 
immobilized such that the maximum response reflects the stoichiometry of binding (n), as described 
in the previous chapter. 
 
Table 3.1: Binding affinity. The dissociation constant (KD), Rmax, and Chi2 are given for 
different protein and DNA complexes as determined by steady state analysis of surface plasmon 
resonance studies. 
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3.4.2 Key amino acid contact residues involved in high-affinity binding between the 
human MBD2 and p66α coiled-coil regions are found in Ephydatia muelleri.  
The human and Ephydatia MBD2 CC regions share 46% identity, whereas the p66α 
peptides share only 37% identity. Yet, the key amino acid residues involved in the human 
MBD2 and p66α coiled-coil complex are largely conserved in Ephydatia (Figures 3.1 and 
3.5), suggesting that, like the human CC regions, binding is largely driven by key 
hydrophobic and electrostatic contacts, and the helical properties of the peptides. 
The coiled-coil typically consists of two or more α-helices wrapped around one 
another. Coiled-coils are characterized by amino acid sequences forming a heptad repeat 
pattern, with positions designated abcdefg; dimerization interfaces form from 
hydrophobic side chains at the a and d positions. In this sequence, the first and fourth 
residues are hydrophobic, and residues in the fifth and seventh position are primarily 
charged or polar (18). Coiled-coil segments may be unfolded in monomeric form and 
then fold during interaction with a binding partner (19). A two-state transition often 
describes the folding and unfolding of coiled coils, i.e., unfolded peptide monomers 
cooperatively fold to form coiled-coil dimers or oligomers (18). 
Parallel and antiparallel coiled-coil dimerization results largely from the 
interdigitation and burial of hydrophobic side chains of one helix into its partner. The 
human MBD2/p66α CC interaction represents an anti-parallel orientation with 
intermolecular, vertical contacts between branched hydrophobic residues. The vertical 
interactions form between residues in the a position of the heptad repeat of one helix and 
the d’ of the other, and the a’ and d positions. Triplet repeats of branched hydrophobic 
residues placed in the a’-a-a’ positions further promote heterodimerization (16). The 
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position of hydrophobic residues in human MBD2 and p66α represents an arrangement 
found to strongly favor heterodimeric, antiparallel coiled-coil formation (16, 20). More 
specifically, hydrophobic interdigitation between the two coiled-coils presents as 
RILVLLI (p66α residues are in italics) (16). 
As mentioned previously, Ephydatia MBD2 p66α CC regions share high identity 
with their human counterparts, regarding the amino acid residues involved in the coiled-
coil binding interface. E.m. MBD2 presents a VVL sequence rather than IVL, while 
Ephydatia p66α offers an RLLV the a-a’ interdigitated sequence between the Ephydatia 
peptides is likely represented by RVLVLLV. Since the side chain of valine is shorter than 
leucine or isoleucine, the presence of valine-227 in human MBD2 may allow closer 
proximity, and therefore tighter packing, of the surrounding side chains at the interface. 
Conversely, the additional valines present at the E.m. interface may prevent tighter 
packing, as the valine side chain may be unable to reach into the binding pockets as well 
as the isoleucine or leucine residues present in the human peptides.  
When the glutamate at position 224 of human MBD2 was mutated to a glycine, 
decreases were observed in both helicity and binding to p66α, showing that pre-formed 
helical content is necessary for binding; this residue is not found on the binding surface 
between the two CCs (16). The coiled-coil regions of Ephydatia MBD2 and p66α both 
have several amino acids that disrupt alpha-helicity (Figure 3.2). Since the high affinity 
interaction between human MBD2 and p66α was shown to be strongly influenced by the 
helical propensity of both prior to binding, the Ephydatia orthologs are unlikely to 
display the same high helical content and, therefore, the same degree of binding as the 
human peptides. 
	   86	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Human and Ephydatia MBD2 and p66α coiled-coil sequence alignments. Top, a sequence 
alignment of the coiled-coil (cc) domains from human and Ephydatia p66α and MBD2 is shown with key 
hydrophobic (yellow) and ionic/polar (cyan) contact residues highlighted and the heptad repeat (a-g) indicated 
above and below the amino acid sequences. Bottom, an anti-parallel sequence alignment showing the position 
of contact residues between the human and sponge proteins, with amino acid residues known to disrupt alpha-
helicity highlighted (grey) for Ephydatia.  
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3.4.3 Ephydatia MBD2 and p66α coiled-coil regions remain largely monomeric in 
solution. 
The human MBD2 coiled-coil region does not form homo-oligomers as often 
observed with coiled-coils. Indeed, the protein remains monomeric in isolation up to a 
concentration of 300 µM. The human p66α coiled-coil, however, forms homo-dimers in 
concentrations above 50 µM, though the monomer remains the dominant form (15). 
Preliminary size exclusion chromatography (SEC) experiments suggested weak binding 
between the Ephydatia MBD2 MBD and p66α coiled-coil regions. We then performed 
sedimentation velocity AUC studies so as to assess the homo-dimerization versus homo-
oligomerization potential of each peptide in isolation and the hetero-dimerization 
potential in complex. These results indicate that Ephydatia MBD2 coiled-coil also 
remains monomeric in isolation up to a concentration of 100 µM (Figure 3.6). Though the 
Ephydatia p66α coiled-coil region largely exists as a monomer at a 100 µM 
concentration, it does exhibit a tendency to homo-dimerize. The sedimentation velocity 
study also indicates that when the two proteins are combined at final concentrations of 
100 µM, monomers, heterodimers, and hetero-oligomers exist in solution. Given that the 
binding constant between the two sponge coiled-coils is 25 µM, a concentration at only 
four times the KD (100 µM) of a weakly binding complex, is likely to show multiple 
species. 
The weak binding suggested by SEC and AUC, along with the low helical 
propensity predicted by Agadir (see results below), prompted us to turn our attention to 
CD and ITC analyses to further explore the helical and binding properties of the 
Ephydatia coiled-coil proteins. 
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3.4.4 Ephydatia MBD2 and p66α display lower helical propensity than their human 
counterparts. 
Agadir is a prediction algorithm that predicts helical propensity of monomeric 
peptides in solution, and is based on the helix/coil transition theory (21). The algorithm 
predicts that the Ephydatia MBD2 and p66α coiled-coil domains do not have the same 
tendency to form α-helices in isolation as with the human orthologs (Table 3.2). CD 
analyses were performed on the isolated domains, so as to determine the relative helical 
!
EmMBD2CC 
Complex 
Emp66αCC 
Figure 3.6: The Ephydatia coiled-coil domains remain largely monomeric in isolation. 
Analytical ultracentrifugation analysis was performed on the individual coiled-coil domains and the 
sedimentation velocity fit using a continuous size distribution (c(s)). The results are shown for 100 
uM concentrations of MBD2 and p66α coiled-coil domains. 
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content of the coiled-coil regions in isolation in comparison to that predicted by Agadir.  
Human MBD2 (25%) and p66α (66%) are more helical than Ephydatia MBD2 (5%) 
and p66α (20%). The thermal stability of the different coiled-coil complexes was 
determined by following molar ellipticity at 222 nm (θ222 nm) as a function of 
temperature. No cooperative transition was observed during the melt of the Ephydatia 
coiled-coils while the human variants do experience this phenomenon. High affinity 
binding between human MBD2 and p66α depends on the helical propensity of their 
coiled-coils (16). Since numerous amino acids known to disrupt alpha-helical structure 
are present in both Ephydatia CC regions, we therefore predicted a lower binding 
constant for the Ephydatia coiled-coil interaction. 
The human complex melts at 338K while the sponge complex does not exhibit a 
cooperative phase transition associated with melting (figure 3.7, bottom). However, the 
complex could only be accurately measured at 13uM, which is below the 25 uM binding 
constant; only a small fraction would be bound at this concentration. The predicted versus 
calculated helicities differed significantly for the Ephydatia coiled-coils. Limitations for 
the Agadir algorithm exist that cause the program to over or underestimate the helical 
content of peptides; these factors may apply in this scenario. For example, the algorithm 
contains no mode for assessing side-chain interactions. The algorithm also assumes that 
there is no energy coupling, other than electrostatic, between residues in the random-coil 
state, although interactions may also result in the formation of beta-turns in solution; the 
algorithm may predict a random-coil. Further, peptides may aggregate in solution thereby 
altering helical propensity. This is another case that Agadir is unlikely to incorporate into 
the prediction. Also, the presence of the tyrosine residue at the beginning of the amino 
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acid sequence likely disrupts the helicity of the peptide; side-chain interactions with the 
peptide helix may alter both the geometry and CD signal. CD analysis of polyalanine-
based peptides with an N-terminal tyrosine residue located at either end of the chain 
sometimes associates with a positive band at 222 nm (22). Thus, a discrepancy emerges 
between the predicted and calculated (i.e., an over-estimation of helicity by Agadir). 
 
 
 
 
 
 
 
 
 
 
 
!!!! Helical!propensity!in!isolation!Coiled1coil!domain! Predicteda! Calculatedb!HsMBD2! 40! 25!Hsp66α! 55! 66!EmMBD2! 26! 5!Emp66α! 8! 20!a!!Based!on!the!AGADIR!algorithm!b!!Based!on!CD!measurements!
Table 3.2: Helical content of the Ephydatia MBD2 and p66α coiled-coils. Percent helicity as 
predicted by AGADIR and calculated from the circular dichroism molar ellipticity at 222 nm (θ222 
nm) is given for the Ephydatia muelleri and Homo sapiens coiled-coil domains. 
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Figure 3.7: Circular dichroism spectra of Ephydatia coiled-coils in isolation and in complex. Top: circular 
dichroism spectra. Bottom: a thermal melt indicating the temperature dependence of the molar ellipticity at 222 
nm from 293 to 358K. 
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3.4.5 Ephydatia MBD2 and p66α coiled-coil regions bind weakly, but bind to human 
p66α and MBD2 coiled-coils, respectively, with higher affinity. 
Preliminary SEC evidence suggested that an Ephydatia muelleri (E.m.) MBD2-
p66α complex binds very weakly  (data not shown), converse to the tight binding 
experience by the coiled-coils in the human (H.s.) complex. We set out to more 
accurately determine the binding constant for the E.m.-E.m. complex. Our lab previously 
determined that the high affinity of the human coiled-coils results from conserved 
hydrophobic and electrostatic interactions between the coiled-coils (CC) and their helical 
content. Since the Ephydatia coiled-coil peptides largely contain the same interacting 
residues, and yet likely experience weak binding as a result of predicted reduced helicity, 
we were curious if the respective Ephydatia coiled-coil peptides would form higher 
affinity complexes when combined with the human coiled-coil regions (i.e., E.m. 
MBD2/H.s. p66α, E.m. p66α/H.s. MBD2).  
Preliminary SEC data suggested that the E.m.-H.s. complexes bind with higher 
affinity (data not shown). ITC was then performed using thioredoxin fusion constructs of 
the coiled-coil domains. Exothermic heat was generated with each injection in all 
experiments. The binding isotherms (Figures 3.8 and 3.9), and the measured binding 
affinity (KD), free energy (ΔG), enthalpy (ΔH), and entropy (-ΔTΔS) for each complex 
(Table 3.3) show that indeed the Ephydatia peptides bind with higher affinity when in 
complex with the human (H.s. p66αCR1/E.m. MBD2CC: KD- 390 ± 30 nM; E.m. 
p66αCR1/H.s. MBD2CC: KD- 1.3 ± 0.11 µM) as compared with the Ephydatia only 
complex (24 ± 0.12 µM). Each complex binds with a stoichiometry of approximately 1:1 
(n ranges from 0.99 to 1.4, Table 1) consistent with heterodimer formation.  
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Of the binding interactions tested, E.m. p66α for E.m. MBD2 complex formation 
reflects the most unfavorable change in entropy upon binding (TΔS: -1.097 kcal/mol) 
despite a favorable change in enthalpy (ΔH -7.405 ± 0.1001 kcal/mol) supporting the 
notion that pre-formed helicity is an important determinant of binding affinity. The ITC 
results further establish a hierarchy regarding favorability of complex formation:  H.s.-
H.s.>E.m. MBD2-H.s. p66α >H.s. MBD2-E.m. p66α >E.m.-E.m. (highest to lowest 
favorability).  
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Figure 3.8: Binding analysis of Ephydatia and human MBD2 and p66α coiled-coil interactions. Isothermal 
titration calorimetry studies indicating the resulting fit and associated data are shown for human and Ephydatia 
MBD2 and p66α coiled-coil domains binding interactions. Top left: human MBD2 and p66α. Top right: 
Ephydatia MBD2 and p66α. Bottom left: Human MBD2 and Ephydatia p66α. Bottom right: Human p66α and 
Ephydatia MBD2. 
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Figure 3.9: Binding analysis of Ephydatia and human MBD2 and p66α coiled-coil interactions. Isothermal 
titration calorimetry studies indicating the experimental data (top panel) and resulting fit (bottom panel) are 
shown for human and Ephydatia MBD2 and p66α coiled-coil domains binding interactions. Top left: human 
MBD2 and p66α. Top right: Ephydatia MBD2 and p66α. Bottom left: Human MBD2 and Ephydatia p66α. 
Bottom right: Human p66α and Ephydatia MBD2. 
 
	   95	  
 
 
 
 
3.4.6 The Ephydatia p55 binding region does not recruit human NuRD core 
components. 
The region between the MBD2 MBD and coiled-coil domain enhances the affinity 
of MBD2 for DNA and behaves as an intrinsically disordered region in isolation, in the 
context of the full-length protein, and when bound to DNA (Desai, M., et al., unpublished 
data). The first and second regions of the human MBD2 p55BR (amino acids 240-316) 
are sufficient to recruit RbAp48, HDAC2, and MTA2, although showing a somewhat 
weaker interaction with MTA2 as compared to the full-length p55BR (Desai, M., et al., 
unpublished data). The human and sponge MBD2 p55BR share 30% identity and nearly 
identical isoelectric points (pI approximately 10). Without a reliable means of assessing 
the capacity of E. muelleri MBD2 p55BR to recruit NuRD components in sponge cells, 
we investigated whether or not the E. muelleri p55BR interacts with the core components 
of human NuRD (MTA1/2/3, HDAC1/2, and RbAp46/48). Full-length, flag-tagged 
sponge p55BR was expressed in human epithelial kidney cells (HEK 293T) and 
immunoprecipitations of cell lysates with an anti-flag antibody were followed by western 
!!!! KD (nM)! n! ∆H (cal/mol)! T∆S (cal/mol)! ∆G (cal/mol) 
 
Hsp66αCR1/HsMBD2CC ! 48 ± 7! 1.3! -9,934 ±127.6! -55.7! -9,878!
Hsp66αCR1/EmMBD2CC ! 390 ± 30! 1.4! -8,989 ±103.6! -238! -8,751!
Emp66αCR1/HsMBD2CC ! 1,300 ± 110! 1.3! -8,922 ±63.14! -903! -8,019!
Emp66αCR1/EmMBD2CC ! 24,000 ± 1,200! 0.99! -7,405 ±100.1! -1,100! -6315!!
Table 3.3: Binding affinity analyses of Ephydatia and human MBD2 and p66α coiled-coil 
interactions. The dissociation constant (KD), change in enthalpy (ΔH), entropy (-TΔS), Gibbs free 
energy (ΔG), and apparent stoichiometry (n) derived from isothermal titration calorimetry studies are 
given for the coiled-coil complexes between human and Ephydatia p66α and MBD2.  
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blot analysis to identify the human NuRD components interacting with the flag-tagged 
p55BR. Figure 3.10 suggests that despite a weak band for human MTA2, full-length 
Ephydatia p55BR of MBD2 does not significantly recruit human MTA2, RbAp48, and 
HDAC2.  
 
 
 
3.4.7 RNAi knockdown of EmMBD2 causes atypical growth patterns in Ephydatia 
muelleri. 
Preliminary data from the RNAi-induced knockdown of the Ephydatia MBD2/3 in 
developing sponges carried by out a collaborator resulted in an atypical growth 
phenotype early in development. This phenotype was characterized by abnormal growth 
patterns at the leading edge of tissue formation and failure to form complete structures 
associated with early developmental steps (i.e., canal structures and osculum). 
 
3.5 DISCUSSION 
The leap from unicellularity to multicellularity represents a major evolutionary step, 
Figure 3.10: Ephydatia MBD2 p55BR does not recruit human NuRD components. The 
Ephydatia MBD2 p55BR-pCMVTag2B plasmid and an empty vector control were transiently 
transfected into high-transfection-efficiency HEK 293T cells.  
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and sponges exemplify an early and successful evolutionary attempt at a collective 
existence. But, it is currently unknown to what extent the evolution of morphological 
complexity was driven by changes in gene content or regulation. Therefore, as the most 
basally extant organism in the animal lineage, Poriferans represent a ripe target of 
epigenetic investigation. The epigenetic capabilities of this most primitive and ancient 
multicellular organism not only represent a base set for all animals, but also provides 
insight into the epigenetic machinery present in the last common ancestor to all 
metazoans.  
Here, we have presented biophysical analyses pertaining to the ability of MBD2 in 
the freshwater desmosponge, Ephydatia muelleri, to bind methylated DNA and recruit 
NuRD components. These studies underscore how changes in MBD2 amino acid content 
over time may have influenced the emergence of the NuRD complex in response to a 
changing DNA landscape. We specifically find that: (1) the capacity to carry out 
methylation-specific epigenetic mechanisms is present in sponges; (2) E. muelleri MBD2 
and p66a can bind, albeit weakly, through their respective coiled-coil domains, despite 
minimal pre-formed helical content; (3) cross-species pull-downs show the E. muelleri 
MBD2 p55BR does not recruit human NuRD core components MTA2, Rbap46/48 or 
human HDAC1/2; (4) RNAi knockdown of MBD2 in E. muelleri results in abnormalities 
to growth and development. 
Previous work has established that helical content can modulate binding affinity of 
the MBD2 and p66α coiled-coil domains (16). The CD and ITC data suggest the 
importance of pre-formed helical content regarding binding affinity and specificity. The 
Ephydatia MBD2-p66α coiled-coil interaction further supports the notion that differences 
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in helical content dictate high affinity coiled-coil binding for the human orthologs, and 
thus, overall NuRD complex formation. As we have observed, though, sponge MBD2 
and p66α need not display high helical content in order to interact. Since MBD2 
homologs (e.g., MBD3, MBD3L1, MBD3L2) are not found in the genomes of 
Amphimedon or Ephydatia, competition for p66α binding is likely reduced in the context 
of forming different NuRD complexes. Thus, high affinity binding may have become 
necessary only when other isoforms emerged.  
MBD2 homologs emerge at the same time as the vertebrate methylation pattern (4), 
which includes largely unmethylated CGIs, suggesting a role for these proteins in 
regulating genes with unmethylated CGIs. Data collected from the RNAi-mediated 
knockdown of MBD2 supports the notion that sponges have a capacity for interpreting 
methyl-cytosines as an epigenetic mark. Ephydatia MBD2 targets methylated sites with 
similar high-affinity binding observed in human and chicken MBD2 isoforms. Sponges 
also lack homologs of MBD2 that may alter the distribution, and thus the functional 
consequence, of MBD2 on DNA. Therefore, sponge MBD2 may not need to bind DNA 
as tightly in order to bring about a physiologic response.   
The role of DNA methylation and methyl-cytosine binding domains has clearly 
changed during the course of metazoan evolution. Expansion of the methylation 
landscape in vertebrate genomes created an environment in which new dynamic 
properties of regulatory proteins were required; expansion of the first MBD’s functional 
role may have occurred concomitant to changes in the DNA methylome.  At the dawn of 
animals, however, the methylation landscape may have initially dictated little need for 
variations of methyl-cytosine binding domain proteins. There may have been little 
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evolutionary pressure for the presence of different NuRD complexes that show varying 
degrees of DNA methylation selectivity and provide distinct functional roles.   
MBD2-directed targeting to mCpGs clearly serves an important developmental role 
for Ephydatia. It is however unclear if the developmental abnormalities observed in 
Ephydatia result from actions directly mediated by an intact NuRD complex. Despite the 
observations collected from our cross-species experiments, it remains reasonable to 
expect the Ephydatia p55BR to recruit Ephydatia NuRD components in sponge cells. 
Differences in amino acid composition between the human and sponge proteins in 
question may prevent E.m-H.s. binding, but not necessarily between the sponge proteins. 
Human and Ephydatia RbAp share 82% amino acid identity and 80% identity is shared 
between the human and sponge HDAC whereas only 42% identity exists between those 
of MTA2. Only 30% identity is shared between the MBD2 p55BR of both species. 
Though sequence differences likely dictate the results observed in these studies, pull-
down analysis in sponge cells is a necessary next step to determine if NuRD formation 
occurs in Ephydatia muelleri.  
It is also possible that a NuRD complex may not form in its entirety in E. muelleri. 
That supposition, however, does not preclude the formation of a functional complex that 
targets methylated DNA and carries out chromatin remodeling. Our observations support 
the possibility of such a complex. Furthermore, the NuRD complex is unique in that it 
couples two separate DNA-related functions, whereas most co-repressor complexes 
perform only one action on DNA (23). It is reasonable that a sponge precursor to the 
NuRD complex may involve only a single regulatory mechanism. However, we cannot 
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conclude that MBD2 does not direct NuRD complex assembly in E. muelleri without an 
ability to perform pull-down assays in sponge cells. 
The paths leading to novel protein functions likely proceed through states in which 
isoforms and relatively unstable structures emerge and coexist (24); one or more of these 
forms may perform new tasks beneficial for the organism resulting in the evolution of a 
new biological function. This scenario might very well be represented by the subtle 
changes over time in the MBD2 p55BR and the coiled-coil regions of p66α, MBD2, and 
the remainder of the MBD family as well. Indeed, the expansion of the MBD family 
appears to correlates with the evolution of their C-terminal coiled-coil regions.  
Research continues to show that NuRD activity largely depends on its specific 
subunits and their interactions. Despite that which is known about the NuRD complex, 
much about the mechanisms of component recruitment, assembly, and localization to 
specific genomic targets remain unclear. These mechanisms undoubtedly influence 
subunit binding affinity and genomic selectivity by the complex, and therefore constitute 
an essential area of study regarding this important genetic regulator. Continued study of 
the evolution of NuRD subunits over time may elucidate these mechanisms. Future 
studies may also uncover how the changing epigenetic landscape, associated with both 
the metazoan-eumetazoan and the invertebrate-vertebrate transition allowed for, or was 
mediated by, the evolution of the NuRD complex.  
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Chapter 4- Summary 
 
Changes to the DNA methylation landscape during the invertebrate to vertebrate 
transition may have accompanied evolutionary pressure for expansion of the MBD 
family. Global methylation patterning likely necessitates a larger ensemble of 
functionally diverse MBD proteins so as to expand regulatory capacity. Much like an 
increase in the quantity and complexity of data contained within a database requires an 
expansion of the database management systems that organize and analyze the data within 
that collection of information. Or, if one views DNA as a manuscript, alterations to the 
story may increase both the cast of characters and the story’s complexity; more people 
may become involved in interpretation of the story’s account of events.     
As with the works of Shakespeare, we are still developing our understanding of the 
meaning of the stories provided to us by nature, and interpreting the menagerie of 
characters encoded within the script. Also like Shakespeare, nature has left us several 
enigmatic characters and plots we have yet to fully comprehend. The studies presented in 
this thesis, Evolution And Divergence Of The Structural And Physical Properties Of DNA 
Binding By Methyl-Cytosine Binding Domain Family Members 2 And 3, pertain primarily 
to two characters in the DNA methylation story. We more specifically provide details 
regarding the mystery surrounding MBD3 function and the MBD2-mediated capacity of 
primitive animals to carry out methylation-specific epigenetic mechanisms. 
In chapter two, ‘Probing the dynamic distribution of bound states for methyl-
cytosine binding domains on DNA, we provide additional details regarding the DNA 
binding properties of MBD2 and MBD3. More specifically, this study provides details 
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regarding previously unidentified MBD3 binding properties and potential biological 
function. Studies establish the two proteins as important epigenetic regulators, and both 
have been analyzed extensively for possible functional differences and similarities. But 
although MBD2 has been well characterized, MBD3 continues to be scrutinized 
regarding its structure and biological function. We found that MBD3 does modify the 
distribution of MBD2 on DNA such that MBD2 spends less time on CpG sites. Thus 
MBD3 could help prevent gene silencing by MBD2 at unmethylated gene promoters and 
enhancers depending on the relative concentration of the two proteins and cellular 
context. These findings correlate with the observations that both MBD2 and MBD3 are 
found at unmethylated CGIs, but MBD2 binds with much greater affinity and likely 
excludes MBD3 from methylated CGIs. The data establishes a structural basis for the 
relative distribution of MBD2 and MBD3 on genomic DNA and help explain their 
observed occupancy at CpG-rich promoters. Further in vivo detail is necessary, though, to 
better assess MBD3 capacity for modulating MBD2 distribution at these sites and the 
functional consequence of such activity.  
In chapter three, ‘Sponge MBD2 targets methylated DNA and recruits NuRD 
components’, we demonstrate that sponges have an MBD2-mediated capacity for binding 
methylated DNA sites and recruiting NuRD components in vitro. We further show that 
knockdown of MBD2 in the freshwater desmosponge, Ephydatia muelleri, promotes an 
abnormal growth phenotype, illustrating the importance of the protein for sponge 
development. Thus, at the dawn of animals, molecular machinery was in place allowing 
for methylation-specific epigenetic regulation that influences developmental processes. 
Further assessment should involve the ability of E. muelleri MBD2 to recruit sponge 
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NuRD components in vitro and in vivo along with analysis of NuRD complex 
functionality in vivo.  
One might associate protein specificity with a lack of structural and functional 
versatility over evolutionary time. Indeed, proteins with absolute functional specificity 
and structures are likely to respond less readily to selective pressures. Structural 
variability consequent to mutation, gene duplication, or other processes, can lead to 
structural flexibility that endows proteins with functional promiscuity and/or, over time, 
allow structural ensembles to diverge into groups separated by distinct structures and 
functions. This situation may have allowed for the divergence of the MBD family from 
the ancestral MBD2/3. The observed flexibility in the finger-like projection connecting 
the central two strands of the β-sheet of MBD2 and MBD3 may exemplify a relationship 
between structural flexibility and evolvability or, at least, functional promiscuity. 
Expansion of both the MBD family and the NuRD functional repertoire may also have 
been promoted by subtle changes over time within the p55BR and coiled-coil regions of 
MBD2 and MBD3. 
Much remains to be learned regarding the evolutionary and biochemical 
foundations of epigenetic processes. Hopefully, this dissertation provides some useful 
insights into the emergence and evolution of the key epigenetic regulators presented and 
how those molecular entities influence heritable changes in gene activity. 
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